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ABSTRACT 
 
Osteoarthritis (OA) is the most common joint disease. Its prevalence increases with age and 
virtually everyone over 65 years of age displays radiologic evidence of the disease. Over one-
third of elderly population experiences symptoms from OA, causing pain and reducing the 
quality of life. In addition to the suffering caused to individual persons, substantial costs to 
the society arise due to this disease. 
Current methods do not enable the diagnosis of the earliest OA changes in joints at a 
stage where spontaneous regeneration of the joint would be still possible. Quantitative and 
sensitive methods to detect early OA changes are needed if one wishes to study the efficacy 
of disease modifying osteoarthritis drugs (DMOADs) and to target their use optimally. 
Several biophysical methods for this purpose have been proposed, but little is known about 
their diagnostic performance and no objective comparison between these methods has been 
performed. Moreover, the effect of site-dependent variation of cartilage properties on 
diagnostic methods has remained unclear. 
The present thesis work examined the effect of cartilage collagen network on its 
mechanical properties, especially on the Poisson’s ratio. Moreover, the sensitivity and 
specificity of several quantitative biophysical diagnostic methods were determined and 
compared, including indentation methods, quantitative MRI (T2 mapping and dGEMRIC) 
and several ultrasound parameters (R, IRC, URI). Further, we assessed the degree of spatial 
variation of mechanical, compositional and acoustic properties within one cartilage surface.   
The results revealed that several of the novel quantitative diagnostic methods possessed 
both good sensitivity and specificity for detecting OA changes in cartilage. The measurement 
results were significantly correlated with the biomechanical properties and composition of 
cartilage. The indentation measurements could be used to quantify the mechanical properties 
of the tissue. However, if one wishes to diagnose tissue normality or pathology, the results 
should be compared with site-matched reference values. Importantly, the results suggest that 
in healthy tissue, no statistically significant topographical variation exists in the values of 
ultrasound reflection from the cartilage surface (p=0.61), and therefore no site-matched 
reference values are needed with this method. Further, the collagen network structure was 
found to be the primary determinant of the Poisson’s ratio of cartilage. 
In conclusion, the mechanical, ultrasound and MRI parameters show potential for 
accurate diagnostic tools for determining cartilage integrity and could be considered when 
determining the efficacy of DMOADs and the results of cartilage repair techniques. After 
effective DMOADs have been developed, these methods may well be suitable to screen 
individuals at risk for OA in order to detect those who might benefit from the medication. 
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Humans; Joints; Magnetic Resonance Imaging; Osteoarthritis; Regeneration; 
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AUC area under the curve 
BMI body mass index 
COX cyclooxygenase 
CRP C-reactive protein 
CT computed tomography 
dGEMRIC delayed gadolinium-enhanced magnetic resonance imaging of 
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DMOAD disease-modifying osteoarthritis drug 
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FE finite element 
FTIRI  Fourier transform infrared imaging 
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MMP matrix metalloproteinase 
MRI  magnetic resonance imaging 
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NIH National Institutes of Health 
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 PG  proteoglycan 
OA  osteoarthritis 
OARSI Osteoarthritis Research Society International 
OATS osteochondral autograft transfer system 
OCT optical coherence tomography 
OD optical density 
RA rheumatoid arthritis 
ROC receiver operating characteristic 
SD standard deviation 
WOMAC Western Ontario and McMaster Universities index for 
osteoarthritis 
Symbols 
α attenuation 
EDYN dynamic modulus of cartilage 
EEQ equilibrium modulus of cartilage 
EUS ultrasound indentation modulus of cartilage 
FIND indentation stiffness of cartilage 
IRC integrated ultrasound reflection coefficient 
n number of samples 
p p-value 
r correlation coefficient 
RUS ultrasound reflection coefficient from cartilage surface 
SOS speed of sound 
T tesla 
T1 T1 relaxation time of cartilage 
T2 T2 relaxation time of cartilage 
URI ultrasound roughness index 
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1  Introduction 
Osteoarthritis (OA) is the most common degenerative joint disease and it 
is responsible for major costs to modern society. It has been estimated that 
20-40% of the elderly population suffers from symptomatic OA (Felson 
1988). Radiographic evidence of OA changes in at least one joint has been 
reported in virtually all the population over the age of 65 years (Lawrence 
et al. 1966). The condition causes a major economic burden to the society 
through lost working time as well as social and medical costs. 
Musculoskeletal conditions, of which OA is the most common, have been 
estimated to consume up to 2.5% of the gross national budget of 
developed countries (March et al. 1997, Yelin et al. 1995). Nonetheless, the 
impact of the disease on the affected individuals and their relatives and 
friends is even greater, as OA causes pain, reduces the ability to perform 
activities of daily living and impairs the quality of life (Brooks 2002). 
In OA, the normal functionality of the joint is disturbed due to 
degenerative processes that affect all components of the joint, in particular 
articular cartilage. Since the cartilage tissue lacks innervation, the early 
OA changes do not usually evoke any symptoms. After the process has 
advanced to a point where spontaneous regeneration of the joint is no 
longer possible, the first symptoms may be detected. At this stage, OA can 
often be diagnosed with current diagnostic modalities, such as plain 
radiographs. Interestingly, the exact origin of the symptoms in OA is still 
unclear (Dieppe et al. 2005). 
There is currently no cure for primary OA, and the etiology of this 
disease remains still unresolved. However, active research is being 
conducted to reveal the mechanisms associated with the early OA changes 
so that subsequent degenerative OA processes could be halted or even 
reversed e.g. with drugs. It is evident that sensitive quantitative methods 
are needed to demonstrate the efficacy of these medications (Qvist et al. 
2008). It is critical to detect OA early enough in order to efficiently target 
the use of these novel therapeutic approaches. Furthermore, the detection 
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of early degenerative changes could help to motivate patients to changes in 
their life-styles, e.g. to effective weight control or changes in working 
conditions. These are known risk factors for OA and can threaten the joint 
health (Cimmino et al. 2005). This could help in preventing the 
inexorable rise in the number of new OA cases (Felson et al. 1998). 
Furthermore, the development of cartilage repair techniques has created a 
demand for quantitative assessment of the results obtained with these 
procedures.  
In the past two decades, several indentation techniques, acoustic 
methods and magnetic resonance imaging (MRI) methods have been 
developed to characterize and quantify cartilage properties. These 
techniques are mostly based on the determination of the properties of 
articular cartilage, which are known to change during the OA process. I.e. 
there can be changes in cartilage composition, the mechanical properties of 
the tissue and surface integrity. However, there are no comparative studies 
of these methods. 
In this thesis work, we compared several novel quantitative methods 
based on magnetic resonance imaging, mechanical and acoustic 
determination of the cartilage properties. The methods are potentially 
suitable for clinical use and in the future they may assist in diagnosing 
early degenerative changes in cartilage.  Furthermore, we characterized the 
structure-function relationships in normal and pathological cartilage to 
better understand the mechanical functioning of cartilage. In addition, we 
clarified the uncertainties induced by the potential change in cartilage 
ultrasound speed during mechano-acoustic measurements of cartilage 
integrity. 
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2  Articular cartilage 
2.1  Structure and composition 
Articular cartilage is highly specialized connective tissue which covers the 
ends of articulating bones in the diarthrodial joints. These joints consist 
of multiple components such as ligaments, supporting muscles and 
synovial membrane lining the synovial capsule (Wooley et al. 2005). The 
unique composition and structure of cartilage tissue enable the 
articulating surfaces to glide over each other with nearly no friction 
(Forster et al. 1996, Mow et al. 1992). Cartilage also acts as a wear-
resistant surface during locomotion, as it absorbs mechanical energy 
during movement and distributes the loads evenly to the underlying 
bones with the help of other components of the joint, such as the menisci 
(Ahmed et al. 1983, Wooley et al. 2005). 
 
 
Figure 2.1 A sagittal section of the structure of the knee joint. Cartilage lines the 
articulating bone ends. The menisci are located between the tibia and femur and 
help to distribute the loads more evenly. 
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Cartilage tissue differs from most other soft tissues. As it lacks a 
vascular system, the nutrients for the cartilage cells, chondrocytes, 
predominantly diffuse from the synovial fluid. Furthermore, cartilage 
tissue has no innervation and therefore its early degenerative changes and 
minor lesions may be asymptomatic. Chondrocytes occupy only 1-2% of 
the total tissue volume (Hunziker et al. 2002, Stockwell 1967), with the 
rest of the tissue being composed of the extracellular matrix (ECM). The 
ECM produced by the chondrocytes consists mostly of proteoglycans 
(PGs) and a collagen fibril network (Huber et al. 2000). 
Chondrocytes are cells of mesenchymal origin. They start their 
differentiation early during embryonic development (Corvol 2000). 
Chondrocytes are the only cell type present in articular cartilage tissue 
and therefore they play key role in determining cartilage health. Although 
a proliferative cohort of chondroprogenitor cells has been detected in 
young and fetal animal cartilage tissue (Dowthwaite et al. 2004, Koyama 
et al. 2008) and adult human chondrocytes have been shown to exhibit a 
low proliferative activity in OA cartilage (Aigner et al. 2001, Mankin et al. 
1971), no actual chondroprogenitor cells have been observed in mature 
articular cartilage. This may impair the ability of adult articular cartilage 
to undergo repair after injury. In normal tissue, the chondrocytes 
maintain the cartilage homeostasis by controlling the anabolic and 
catabolic activity within the tissue. Then, the slow ECM component 
synthesis is in balance with the minimal and controlled activity of 
degrading enzymes, released to the surrounding ECM by the chondrocytes 
(Goldring 2000). 
The synovial fluid in the joint cavity lubricates the contacting 
articular surfaces, contributing to the very low friction properties of the 
opposing cartilage surfaces. This viscous fluid secreted by the cells in the 
synovium contains mainly water, nutrients for chondrocytes, proteins and 
electrolytes (Fam et al. 2007).  
Once articular cartilage has matured after the age of 20 years, its 
components have a very long lifetime and a slow rate of turnover (Bank et 
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al. 1998). In ECM, collagen has been evaluated to have a half-life of over 
100 years (Verzijl et al. 2000). Therefore, in healthy cartilage, the turnover 
rate of proteins is very slow and the enzymatic degradation of ECM is 
minimal. The slow rate of turnover restricts the capacity of spontaneous 
regeneration after cartilage damage and this makes cartilage vulnerable to 
degeneration. The half-life of PGs is faster than that of collagens, varying 
from 3 to 25 years between different components of PGs (Maroudas et al. 
1998). 
2.2  Collagen fibril network 
Collagen is the main protein in cartilage and in many other connective 
tissues. In cartilage, most collagen is type II, although small amounts of 
other types of collagen (III, IX, X, XI) have also been identified (Eyre 
2002, Eyre et al. 2006). The variable types of collagens in articular 
cartilage play different roles in creating the typical fibrillar structure 
within the tissue (Eyre 2004). Type II collagen is synthesized by 
chondrocytes as procollagen, which consists of three alpha (II) chains 
(Prockop 1979). The procollagen molecules are secreted into ECM, where 
the N- and C-terminal propeptides of the molecules are enzymatically 
removed. The new collagen molecules exhibit a unique triple helical 
structure and they spontaneously assemble to form thin collagen fibrils. 
In tissues, collagen fibrils are packed together into more organized fibers 
which are responsible for the high tensile strength and dynamic 
compressive modulus of cartilage (Bader et al. 1981, Bader et al. 1992, 
Bader et al. 1994). The type II procollagen synthesis is most active during 
embryonic development (Nelson et al. 1998). The development of randomly 
oriented collagen fibrils has been suggested to create a scaffold, which 
develops into the typical three-dimensional highly specialized zonal            
. 
 20 
  
Figure 2.2 Structure of articular cartilage. The collagen fibrils in the superficial 
zone form a dense network that can resist high tensile forces. In the transitional 
zone, the orientation of the fibrils shows transition in their alignment. In the deep 
zone, the fibrils are aligned perpendicular to cartilage surface. The interface 
between the deep cartilage and the calcified cartilage is called the tidemark. The 
dense subchondral bone plate lies below the calcified cartilage layer. Under this 
layer, the bone transforms into trabecular bone. 
architecture. This process may be activated by external loads, e.g. with the 
help of exercise (Helminen et al. 2000).In mature articular cartilage, the 
collagen fibers are arranged in a tri-laminar structure (Benninghoff 1925), 
as presented in Figure 2.2. The collagen fibers in the superficial zone are 
oriented in parallel to the cartilage surface, forming a wear-resistant 
 21 
meshwork that resists tensile and dynamic compressive loads during 
movement. In the layer below the superficial one, the transitional zone, 
the collagen fibers descend towards the deep cartilage and the orientation 
of the fibers is more random. In the deep or radial zone, the collagen fibers 
run perpendicular to the cartilage surface and are linked to the 
subchondral bone. The deepest cartilage is calcified and is separated from 
the uncalcified cartilage by the thin tidemark layer. 
2.3  Proteoglycans 
Proteoglycans (PGs) are macromolecules composed of a core protein to 
which the glycosaminoglycan (GAG) chains are attached (Carney et al. 
1988, Hardingham et al. 1992). The numerous negatively charged GAG 
side chains in PGs repel each other and this creates an osmotic imbalance, 
which is partially balanced by the presence of positively charged cations 
and influx of water into the cartilage tissue. Up to 90% of the total PG 
mass of cartilage is composed of large aggregating PGs (Huber et al. 2000). 
The PGs and hyaluronan associate to form large PG aggregates. Link 
proteins serve to stabilize PG aggregates and increase the size of the 
aggregates (Hardingham et al. 1974). The large size of the PG aggregates 
prevents the free redistribution of PGs despite the osmotic imbalance, and 
this leads to an influx of water into the cartilage and as a consequence to 
the expansion of the tissue matrix. This interaction between PGs, water 
and cations creates a positive swelling pressure, which is restricted by the 
stiff collagen network (Maroudas 1976, Mow et al. 1992). 
2.4  Structure-function relationships in normal and degenerated 
cartilage 
Articular cartilage is a permeable viscoelastic tissue with unique 
mechanical properties. The mechanical properties of the tissue can be 
characterized by determining e.g. the dynamic and equilibrium moduli of 
the tissue. Further, the lateral expansion of tissue under compression is 
described by Poisson’s ratio of the tissue, i.e. the lateral to axial strain 
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ratio at equilibrium. These mechanical parameters and thus the function 
of the tissue are controlled by the composition and interactions between 
the main components of the cartilage, i.e. the solid phase with collagen 
network and inbound PGs, interstitial water and the ion phase with 
mostly positively charged cations (Kempson et al. 1970). In normal 
cartilage tissue, loading of the cartilage increases its internal pressure. 
Collagen fibrils resist the change in the shape of the tissue, and therefore 
in the presence of a persistent loading, the increased pressure causes a flux 
of water out of the cartilage tissue until a mechanical equilibrium is 
achieved. This balance during static loading is mainly controlled by the 
PG content of the tissue (Kempson et al. 1970). Therefore, the loss of PGs 
usually results in a decrease of the equilibrium compressive modulus of the 
tissue. The flow of the interstitial fluid is reflected by the permeability 
properties of the tissue. On the other hand, if the collagen network of the 
cartilage is damaged or the collagen content is reduced, a decrease in the 
dynamic modulus of the tissue can typically be observed. 
Changes in the mechanical properties of the tissue also alter the 
functional capacity of cartilage to withstand normal loading. Therefore 
unfavorable changes in the mechanical properties may make cartilage more 
sensitive to further injuries. 
The structure-function relationships have been intensively studied in 
articular cartilage with and without spontaneous OA changes as well as 
with cartilage samples that have been enzymatically treated to degrade 
either tissue collagen or proteoglycans (Bader et al. 1992, Bader et al. 
1994, Rieppo et al. 2003). Typically, the dynamic or equilibrium response 
of cartilage could not be fully explained by the cartilage composition. This 
emphasizes the fact that cartilage is not simply a sum of its primary 
components and that the mechanical response of cartilage depends on the 
structure of the collagen network as well as on the interactions between its 
different components. 
Several theoretical models have been developed to better understand 
the mechanical functionality of cartilage. The first mechanical model for 
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indentation of cartilage was the elastic single phasic model (Hayes et al. 
1972). Later studies have incorporated the viscoelastic (Parsons et al. 
1977) nature of cartilage and poroelasticity of the ECM  into the biphasic 
model (Mak et al. 1987, Mow et al. 1980). In the most recent mechanical 
models, cartilage is modeled as poroviscoelastic material with complex, 
inhomogenous intrinsic structure. The effect of both PGs and collagen 
network on the mechanical behavior of cartilage is also incorporated. 
These models have been shown to predict accurately the mechanical 
behavior of cartilage during loading (Julkunen et al. 2008). 
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3  Osteoarthritis 
3.1  Etiology and pathogenesis of osteoarthritis 
 
Figure 3.1 Characteristic changes that take place during the OA process include 
fibrillation and cleft formation and alterations in mechanical properties of 
cartilage. Osteophyte formation, subchondral bone sclerosis and cyst formation 
are typical changes in bone associated with OA. 
Osteoarthritis is the most common joint disease. It has been described to 
affect most joints of the human body; however, in clinical practice most 
important and most prevalent are knee, hip, hand, foot and spine OA. 
The disease is a continuum, where the earliest detectable degenerative 
changes include loss of PGs in the superficial layer of cartilage. An 
important step in OA is the initial fibrillation of the superficial collagen 
network (Buckwalter et al. 1997, Dodge et al. 1989, Mow et al. 1992). The 
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deterioration of the supporting collagenous meshwork leads to influx of 
water leading to a decrease in PG content of superficial cartilage. The 
initial loss of PGs from the superficial cartilage induces a steeper swelling 
pressure gradient in the deeper cartilage (Maroudas 1976). Therefore, a 
greater stress on the collagen network in deeper cartilage may occur, which 
exposes the cartilage to create the formation of deeper fissures, clefts, first 
in the transitional zone and these then progress into the radial zone and 
this worsens the damage to articular cartilage. As PGs and collagen are 
responsible for providing the structural and mechanical integrity of the 
cartilage tissue, the mechanical properties of cartilage are also typically 
impaired at an early stage (Knecht et al. 2006).  
Healthy cartilage tissue maintains its integrity during a very slow 
renewing process. This seems to be most active around the chondrocytes 
and at the bone-calcified cartilage junction. The synthesis of matrix 
components is in equilibrium with the slow actions of enzymes that 
degrade the extracellular matrix. The metabolic activity of chondrocytes 
has been reported to increase in OA cartilage, perhaps the cells attempt to 
combat the tissue degeneration (Mankin et al. 1970). Several enzymes that 
degrade the components of articular cartilage tissue have been 
characterized (Cawston et al. 2006). Matrix metalloproteinases (MMPs) 
are regarded as the most important group of these enzymes, and an 
imbalance between the degrading enzymes and their inhibitors has been 
detected in OA (Dean et al. 1989). Other degrading enzymes, such as 
aggrecanases, have also been detected and their role in the development of 
OA is being studied (Burrage et al. 2007). Doubtlessly, OA process 
involves disruption of the strictly controlled homeostasis in cartilage. 
Indeed, OA has been demonstrated to induce increased release of collagen 
degradation products into synovial fluid (Lohmander et al. 2003) and 
serum (Christgau et al. 2004). The detection of these degradation 
products may help in diagnosing the earliest OA changes. 
Since adult articular cartilage has a very limited capacity for 
spontaneous repair, originally small lesions may potentially progress to 
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OA if the degradative processes continue and overwhelm repair strategies 
(Huber et al. 2000). The cartilage defects in symptomatic OA tend to 
progress (Davies-Tuck et al. 2008). Therefore, once the patient develops 
symptomatic OA, the disease severity typically increases gradually with 
time (Felson et al. 1995). Therefore advanced OA is typically characterized 
by a progressive erosion of the articular surface followed by gradual 
denudation of the joint surface. 
During the OA process, the subchondral bone is also altered. Cartilage 
and bone changes have been suggested to interrelate, at least to some 
extent (Felson et al. 2004b, Karsdal et al. 2008). Subchondral sclerosis 
and formation of the osteophytes are typical features of OA, and 
subchondral bone cysts are relatively frequently observed in advanced 
disease (Hayes et al. 2005). It has also been suggested that the 
subchondral bone sclerosis and stiffening would be one initiator of the OA 
process. This would cause an increase in the loading applied to cartilage 
(Radin 1976), with an associated secondary change of its structure. 
According to this hypothesis, the changes in cartilage would be secondary 
and take place subsequent to alterations in subchondral bone. 
Several causes of secondary osteoarthritis have been identified and 
include factors such as high intensity impact joint loading, intra-articular 
fractures, ligament injuries and several metabolic disorders (Buckwalter et 
al. 1997, Buckwalter 2002, Buckwalter et al. 2006, Mitchell et al. 1977). In 
secondary OA, the degenerative changes in cartilage occur as a consequence 
of some trigger which endangers the mechanical integrity of the tissue, 
typically by damaging the collagen network of cartilage. However, in most 
cases, no such cause can be identified and the disease is termed primary 
OA. The etiology of this disease is still unclear (Buckwalter et al. 2004). 
Although primary OA is very strongly associated with increasing age 
(Crepaldi et al. 2003, Kirkwood 1997), it should not be regarded as 
“normal wear and tear” (Buckwalter et al. 1997). 
Several risk factors for primary OA have been identified in large-scale 
follow-up studies (Arden et al. 2006, Buckwalter et al. 2004, Cimmino et 
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al. 2005, Felson et al. 1997, Felson et al. 1998, Felson et al. 2000, Felson 
2004, Sangha 2000). The prevalence of OA has long been known to be 
more common in women (Buckwalter et al. 2000), and therefore the 
involvement of sex hormones has been proposed. Another factor elevating 
the risk for OA is increased body weight, i.e. body mass index (BMI) 
(Felson et al. 1988, Schouten et al. 1992, Spector et al. 1994), especially 
when it is combined with malalignment of the joint (Felson et al. 2004a, 
Sharma et al. 2000). Earlier knee trauma is a risk factor for later knee OA 
(Gelber et al. 2000), particularly if it involves either partial or total 
menisectomy (Roos et al. 1998). This arises due to the critical role of the 
meniscus in distributing the loads evenly between the femoral and tibial 
joint surfaces and the removal alters the load distribution. Both direct 
injury and menisectomy may expose cartilage to mechanical overloading, 
which can damage the cartilage and lead to OA (Kurz et al. 2005, Mankin 
1982). Further, in animal models, strenuous running exercise has induced 
alterations in the cartilage collagen network, which may be indicative of 
degenerative changes and possible future cartilage degeneration (Arokoski 
et al. 1996, Brama et al. 2000). However, the effect of exercise as a risk 
factor in humans is more unclear (Urquhart et al. 2008). It appears that 
large individual variation exists in the ability of cartilage to withstand 
loading. Possible explanations for this could be variations in the PG 
content of cartilage, as it has been shown in animal studies that the PG 
content of cartilage decreases during immobilization (Kiviranta et al. 
1987). After the PGs have been depleted, strenuous loading of the joint 
may cause irreversible damage by disrupting the reversal of the atrophic 
changes (Palmoski et al. 1981) and this can initiate the OA process in the 
joint (Buckwalter 1995). It is evident, however, that participation in 
strenuous types of sports may jeopardize the health of load bearing joints 
(Lane et al. 1999, Marti et al. 1989). 
Overall, it has been suggested that clinical OA could represent a 
cluster of conditions of different origins leading to the same endpoint 
(Hart et al. 1995, Mitchell et al. 1977). In addition to articular cartilage, 
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OA affects all components of the joint, including synovium, subchondral 
bone and ligaments (Aigner et al. 2006, Brandt et al. 2006). 
OA is often clustered in families. This has led to thoughts that genetic 
factors predispose to this disease (Cicuttini et al. 1996, Kellgren et al. 
1963). This was confirmed by results from a twin study, where the 
heritability of OA was estimated to range from 39% to 65% (Spector et al. 
1996). However, even in the early studies of OA genetics, it was noted that 
primary OA does not follow a simple Mendelian heritability (Kellgren et 
al. 1963). This suggests that the disease is not caused by a single gene 
mutation and, to date, no single gene mutation to account for all OA 
cases has been identified. Therefore the genetic predisposition to OA has 
been interpreted as signifying a multifactorial disease (Bateman 2005) and 
several genetic loci for OA susceptibility genes have been identified (Aigner 
et al. 2003, Peach et al. 2005). 
3.2  Prevalence of osteoarthritis 
The development of radiological criteria for OA in the 1950s by Kellgren 
and Lawrence made it possible to conduct studies to determine the 
prevalence of radiographic OA (Kellgren et al. 1957). From the 1980s, 
extensive population based studies have been carried out to examine the 
prevalence of radiological and symptomatic OA. The studies have mostly 
evaluated OA in knee joints or hands. These studies have revealed that 
prevalence of OA increases with age. Further, women are more often 
affected by this disease. Since the percentage of population over 65 years of 
age is on the increase, the total number of patients suffering from this 
disease has been estimated to increase in the near future. However, the 
incidence of knee OA has been reported to decline in women under 75 
years, but to increase in men over 85 years of age in a Finnish population 
based study (Heliövaara et al. 2007).  
OA is a very common musculoskeletal disorder (Lawrence et al. 2008, 
Petersson 1996, van Saase et al. 1989) It is estimated to be the most 
common chronic condition that causes limitation in activity in population 
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over 45 years of age (Verbrugge et al. 1995). In large-scale studies using 
radiographic imaging, evidence of OA changes has been detected in 
practically all individuals older than 65 years of age (Lawrence et al. 
1966). The lifetime risk of symptomatic knee OA has been estimated to be 
45% in the general population, and it has been calculated to affect nearly 
2 out of 3 persons with an elevated BMI (Murphy et al. 2008). The 
reported incidence of OA in population studies varies extensively (Table 
3.1). The discrepancy between the results is partially explained by the 
differences in methodology, i.e. some studies included only radiographic 
evaluation of certain joints, others have included also extensive physical 
examination together with radiographic imaging. Furthermore, the 
prevalence between different geographic areas and populations seem to 
explain part of the variation (Corti et al. 2003). In studies conducted in 
the USA, the prevalence of radiographic knee OA has been found to reach 
55.6% in women and 40.7% in men over 80 years of age (Dillon et al. 
2006). When symptomatic OA is defined as a disease in which the patient 
experiences frequent pain in a joint with radiographic evidence of OA, the 
prevalence of symptomatic knee OA has been estimated to achieve values 
up to 18.7% and 13.2% for female and male populations over 45 years of 
age, respectively (Jordan et al. 2007). A recent extensive Finnish 
population study evaluated the prevalence of knee OA to be higher than 
that of American population (Arokoski et al. 2007). However, in that 
study, the evaluation did not systematically include X-ray imaging of the 
joints, and thus the diagnosis was based on a thorough clinical 
examination supported by earlier medical history and imaging studies. A 
subgroup analysis of this study revealed also high rates for radiologic OA 
in Finnish population as well as a moderate agreement between the 
clinical and radiological diagnosis (Toivanen et al. 2007). 
Hand OA is even more common than knee or hip OA. Typically, 
radiographic OA changes in the small joints of the hand can be detected 
in virtually everyone over 70 years of age (Hochberg et al. 1993, Lawrence 
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et al. 1966), but only about one-fourth of them experiences a symptomatic 
disease (Zhang et al. 2002). 
The high prevalence of OA explains partially the massive burden of 
this disease on individuals and societies. Furthermore, the burden is 
increased by the chronic nature of the disease, i.e. once individuals 
develop symptomatic OA, they will suffer from the disease for the rest of 
their lives (Buckwalter et al. 2004). The disease hinders the functional 
capacity of the individuals, restricts their social activities and well-being 
(Brooks 2002, Carr 1999). Furthermore, costs are generated directly and 
indirectly as medical and social costs and absence from work. Indeed, the 
total burden of all musculoskeletal disorders has been estimated to be 
equivalent to between 1-2.5% of the total gross national product (March et 
al. 1997, Yelin et al. 1995). 
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Table 3.1 Prevalence of OA. 
Prevalence (%) Reference, number of subjects Diagnostic 
method 
Age 
(years) Male Female Total 
Knee OA      
The Framingham Study, n=1424 (Felson et 
al. 1987) 
Radiographic 63-94 
63-69 
70-79 
80- 
30.9 
30.4 
30.7 
32.6 
34.4 
25.1 
36.2 
52.6 
33.0 
27.4 
34.1 
43.7 
Johnston County OA project, n=3018, 
(Jordan et al. 2007) 
Radiographic 
Symptomatic* 
45- 
45- 
23.7 
13.5 
31.0 
18.7 
27.8 
16.4 
NHANES III, n=2415 (Dillon et al. 2006) Radiographic 
 
 
 
Symptomatic* 
60- 
60-69 
70-79 
80- 
60- 
60-69 
70-79 
80- 
 
27.4 
33.5 
40.7 
 
7.5 
12.9 
12.7 
 
35.2 
44.6 
55.6 
 
10.6 
15.3 
18.2 
37.4 
 
 
 
12.1 
Kuopio OA 2000 Study, n=130, (Toivanen 
et al. 2007) 
Radiographic 45-82 26.8 23.6 24.6 
Health 2000 Survey, Finland n=6354, 
(Kaila-Kangas 2007) 
Clinical 30-44 
45-54 
55-64 
65-74 
75-84 
85- 
0.3 
2.7 
9.1 
10.8 
15.6 
44.2 
0.4 
2.2 
8.2 
18.2 
32.1 
35.6 
 
Hip OA      
(Lawrence et al. 1966) ** n=567 Radiographic 55- 18.7 9.2 13.4 
Health 2000 Survey, Finland, (Kaila-Kangas 
2007) 
n=6354 
 
 
 
Clinical  
 
30-44 
45-54 
55-64 
65-74 
75-84 
85- 
0.5 
1.8 
5.2 
12.2 
20.4 
39.8 
0.4 
0.8 
3.1 
11.5 
20.4 
24.5 
 
Hand OA      
The Framingham Study, n=1041, (Zhang et 
al. 2002) 
Symptomatic* 71-74 
75-79 
80- 
16.4 
11.9 
13.5 
27.2 
26.1 
26.0 
 
n=317, (Hochberg et al. 1993) Radiographic 40-49 
50-59 
60-69 
70-79 
80- 
 21.4 
58.8 
83.5 
96.0 
100.0 
 
*Symptomatic OA (Presence of joint symptoms in at least one joint with 
radiographic evidence of OA in the same joint) 
**Data adapted from Lawrence 1966 by calculating the percentage of all studied 
people over 55 years of age with radiographic hip OA despite the presence or 
absence of RA. 
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3.3  Treatment and prevention of osteoarthritis 
Several global organizations and authors have published guidelines for 
good treatment of OA (Altman et al. 2000, Conaghan et al. 2008, Working 
group established by the Finnish Medical Society Duodecim and the 
Finnish Orthopaedic Association 2007). Currently, there is no effective 
treatment to slow down or stop the OA process. Therefore, the treatment 
mainly emphasizes the alleviation of the symptoms and pain management. 
Further, it would be optimal if the treatment could improve and maintain 
the functional capacity of the patient. It has been recognized that the 
treatment of OA should be tailored individually, and if applicable, it 
should always include non-pharmacological treatments such as patient 
guidance, exercises and weight reduction (Dieppe et al. 2005, Felson et al. 
1992, Jordan et al. 2003, Roddy et al. 2006). Exercise has been shown to 
have beneficial effects in patients with OA (Bennell et al. 2005, Ettinger et 
al. 1997). Although the effect of this approach is usually limited (Fransen 
et al. 2008), it should be regarded as a first line treatment together with 
the empowerment of the patient. 
3.3.1  Pharmacological pain control strategies 
Most therapeutic recommendations agree that when the non-
pharmacological intervention is not sufficient in treating pain, the 
pharmacological treatment should begin with paracetamol because of its 
favorable efficacy-safety profile (Bannwarth 2006, Jordan et al. 2003). 
Topical analgesics or peroral non-steroidal anti-inflammatory drugs 
(NSAIDs) should be considered for those patients, who are unresponsive 
to paracetamol. However, since NSAIDS may be superior to paracetamol 
(Towheed et al. 2006), some experts consider that NSAIDs should be used 
as the first-line oral analgesics. The gastrointestinal problems associated 
with NSAIDs must be taken into account for individuals at risk and the 
cyclooxygenase 2 (COX-2) selective NSAIDs can be used for patients who 
exhibit a higher risk for suffering gastrointestinal side effects. Lately, the 
cardiovascular safety of COX-2 selective and other NSAIDs has been 
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debated. Currently, COX-2 selective medications are contraindicated for 
people with ischemic heart disease and hypertension if the blood pressure 
is over target values. Opioid analgesics, such as codeine and tramadol can 
be used as such or combined with paracetamol in patients for whom 
NSAIDs are contraindicated, ineffective or poorly tolerated (Jordan et al. 
2003). Furthermore, novel approaches in treating pain in patients with 
OA are being developed and include modulation of the sensory protein 
response at the nociceptive nerve endings (Schaible et al. 2006). 
Intra-articular treatment with hyaluronan or glucocorticoid injections 
has also been utilized (Gerwin et al. 2006). These therapies seem to 
provide temporary relief of pain in certain patients, but no convincing 
evidence for disease-modifying effects has been demonstrated (Ayral 2001, 
Gossec et al. 2006). 
3.3.2  Quest for disease-modifying osteoarthritis drugs 
It has been proposed that the initial degenerative changes are still 
reversible in the very first stage of the OA process. This is why the early 
detection of the cartilage impairment is so crucial. Currently, intensive 
research is being conducted to find ways to stop or reverse the 
degenerative processes in cartilage (Pelletier et al. 2007, Steinmeyer et al. 
2006). Commonly, these drugs are called disease-modifying osteoarthritis 
drugs (DMOADs) (Goldring 2006) or structure-/disease-modifying agents 
for osteoarthritis (Altman 2005). The quest for these drugs by the 
pharmaceutical industry has been continuing for a long time without any 
major breakthrough (Qvist et al. 2008).  
Several studies for pharmacological intervention aimed at slowing 
down, stopping or even reversing the OA process are being conducted 
(Krasnokutsky et al. 2007, Pelletier et al. 2005, Pelletier et al. 2007). Since 
OA is recognized as affecting all components of the joint, it has been 
suggested that the medical treatment should also target all of these 
components (Goldring 2006). Increased knowledge about signaling 
pathways within the chondrocyte might be one way to find solutions to 
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influence the reparative, catabolic and inflammatory reactions (Goldring 
et al. 2004, Malemud et al. 2003), and the ultimate goal is to cease or even 
reverse the degenerative processes within the joint. Attempts have been 
made to alter the matrix metalloproteinase (MMP) response within the 
joint using MMP-inhibitors (Burrage et al. 2007, Cawston et al. 2006, 
Murphy et al. 2005) or by inhibition of MMP gene expression (Mix et al. 
2004) and by modifying the cytokine cascade with interleukin (IL) 1b-
inhibitors (Braddock et al. 2004). Furthermore, it has been suggested that 
the OA process might be modulated by targeting the processes associated 
with subchondral bone turnover (Karsdal et al. 2008). Therefore, drugs 
originally intended for treating osteoporosis, such as the bisphosponates 
(Bingham et al. 2006, Spector et al. 2005) and calcitonin (Bagger et al. 
2005, Karsdal et al. 2007, Manicourt et al. 2006) have been proposed for 
the treatment of OA. These compounds have been shown to induce a 
significant reduction in biochemical cartilage degradation markers (Bagger 
et al. 2005). However, clinical trials with these pharmaceuticals have not 
been able to reveal any effect on the progression of the disease (Qvist et al. 
2008). Doxycycline (Brandt et al. 2005) and diacerein (Dougados et al. 
2001) have also been suggested to function as DMOADs, and studies are 
continuing with substances affecting the inducible nitric oxide synthase 
(iNOS) (Adis R&D Profile 2007). Furthermore, some attempts have been 
made to exploit gene therapy for the treatment of osteoarthritis (Evans et 
al. 2004, Evans et al. 2006, Frisbie et al. 2002, Goldring 2006). Regulation 
of the expression of genes responsible for producing ECM has been 
proposed as a potential way of reversing the OA process (Okazaki et al. 
2004). 
In some countries, glucosamine and chondroitin sulphate are labeled as 
dietary supplements, whereas in other countries they require a 
prescription. Their mechanism of action is unknown, but in some studies 
they have been claimed to confer a chondroprotective action, slowing the 
progression of the disease (Reginster et al. 2001). However, convincing 
evidence of their effect is still lacking. They are known to be partially 
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absorbed in the gastrointestinal tract (Ronca et al. 1998), but their 
actions within the joint are still unclear. In all studies, both glucosamine 
and chondroitin sulphate have been shown to be tolerated as well as 
placebo. Several studies supported or performed by the manufacturer of 
these agents have claimed to demonstrate a pain-relieving effect of these 
agents (McAlindon et al. 2000). However, because of concerns about the 
quality of the trials, meta-analyses were performed and no statistically 
significant benefit of glucosamine for pain or functionality was found 
(Towheed et al. 2005). Furthermore, an independent double-blinded 
study, funded by the National Institutes of Health (NIH) with the same 
aim, failed to confirm the efficacy of glucosamine, chondroitin sulphate or 
their combination (Clegg et al. 2006). 
Several promising molecules are in pre-clinical trials, and some have 
advanced to clinical trials for OA treatment (Goldring 2006, Qvist et al. 
2008). One major obstacle is the difficulty in developing diagnostic 
methods for early cartilage degeneration, and subsequently for monitoring 
the effect of these novel pharmaceuticals (Goldring 2006, Qvist et al. 
2008). In order to determine the efficacy of these novel medications, it is 
crucial to develop novel methods which are capable of sensitively detecting 
the effects of each treatment. 
3.3.3  Surgical treatments 
Operative treatment is often considered in advanced OA when medical 
treatment fails to alleviate pain sufficiently (Jordan et al. 2003). 
Arthroscopic lavage and débridement are typical arthroscopic procedures 
used to treat patients who are unresponsive to pharmacological therapy 
(Frizziero et al. 2005, Segal et al. 2006). In uncontrolled studies these 
procedures have had a limited effect on OA symptoms, in particular it has 
proved difficult to select those patients who would benefit most (Dervin et 
al. 2003). However, in blinded and randomized studies, no difference 
between the groups that had gone through actual or sham procedures has 
been noted (Bradley et al. 2002, Moseley et al. 2002). High tibial 
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osteotomy has been used to treat the medial compartment OA of the knee 
by surgical realignment of the loading axis of the limb. Once again, the 
results with these procedures are somewhat contradictory (Brouwer et al. 
2005). 
In progressive OA, only arthroplastic surgery can alleviate the pain 
and improve the functionality of the joints (Franceschini et al. 2005, Katz 
2006). Although the operation is costly, it has been evaluated as being 
cost-effective (Chang et al. 1996). The annual rate of total joint 
replacement has increased (Katz 2006), and OA is the most common 
indication for total knee replacement. In Finland, the incidence of primary 
total hip replacements in the year 1999 was 93/100,000 (Puolakka et al. 
2001), whereas the incidence for primary total knee replacements in Great 
Britain was 62/100,000 and 70/100,000 for men and women, respectively 
(Dixon et al. 2004). 
3.3.4  Cartilage repair techniques 
Several cartilage repair techniques have been developed and several of 
these are in clinical use. The microfracture technique, osteochondral 
transplants (Mosaicplasty or osteochondral autograft transfer system 
[OATS]) and autologous chondrocyte implantation are techniques used to 
repair articular cartilage lesions. The first clinical applications of artificial 
engineered cartilage have been introduced lately and intensive research is 
being conducted to develop even more efficient techniques and materials 
for cartilage repair. Currently, these techniques are used for treatment of 
localized cartilage lesions, mostly of traumatic origin. Generalized OA is 
not an indication for these procedures. However, attempts have also been 
made to treat primary OA using tissue-engineering techniques. Biologic 
solutions, manufactured using tissue-engineering techniques are also being 
sought to replace metal prostheses with viable biological materials (Nesic 
et al. 2006, Schurman et al. 2004). Also then, improved diagnostic 
techniques are needed to quantitatively assess the benefits of cartilage 
repair techniques. 
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3.3.5  Prevention of osteoarthritis 
As in any disease, the prevention of OA should be practiced at all levels to 
minimize the incidence and total burden of the disease (Felson et al. 
1998). Measures should be targeted at modifiable risk factors. The most 
important targets include reduction of obesity, prevention of knee injuries 
and modification of activities, particularly those involving lifting heavy 
loads or bending on knees. If it were possible to achieve these targets, then 
it has been estimated that over half of all new OA cases could be 
prevented (Felson et al. 1998). 
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4  Clinical methods for diagnosis of osteoarthritis and 
cartilage degeneration 
4.1  Current methods and criteria for OA diagnosis 
In clinical practice, patient history and clinical examination are the two 
first steps in diagnosing any joint disease (Dieppe et al. 2005). The 
patient is asked about the development, duration and type of symptoms. 
Joint stiffness is often present, and pain typically increases during loading 
and alleviates at rest, but in advanced OA, also pain at rest and night 
pain may be present (Dieppe et al. 2005, Hunter et al. 2006). 
The physical examination includes careful inspection of the affected 
joint e.g. for signs of inflammation or deformation. The joint is also 
palpated, whereby deformation and tenderness of the joint can be further 
evaluated. The range of movement of the joint and the stability of the 
ligaments around the affected joint are also tested (Hunter et al. 2006). 
Effusion of the joint can be present. If needed, further tests or imaging 
procedures can be undertaken to support the clinical diagnosis of OA or 
to rule out other diseases. This all aims at achieving a comprehensive 
evaluation of the affected joint. 
Several diagnostic criteria have been presented for hand, knee and hip 
OA, but most commonly used are those published by the American 
College of Rheumatology (Altman et al. 1986, Altman et al. 1990, Altman 
et al. 1991). However, all diagnostic strategies have certain limitations and 
none of these methods has gained as universal approval as the Kellgren-
Lawrence classification for OA features in radiographs (Peat et al. 2006, 
Sangha 2000). The clinically defined OA diagnosis can be set based on the 
symptoms of the patient and findings from physical examination of the 
patient (Felson 2006, Lane 2007). The subjective symptoms of the patients 
can be assessed with different questionnaires, such as Western Ontario 
and McMaster Universities index for Osteoarthritis (WOMAC) 
(McConnell et al. 2001), but these are not used routinely in clinical 
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practice (Fioravanti et al. 2005). The clinical-radiological criteria require 
that the patient has frequent pain in a joint with radiographic OA 
changes. The most often utilized imaging technique in OA diagnostics is 
X-ray imaging. 
4.1.1  Radiography 
The most widely used radiographic classification system for OA was 
introduced by Kellgren and Lawrence in 1957 (Kellgren et al. 1957). The 
criteria are based on visual evaluation of the joint space, subchondral 
sclerosis and detection of osteophytes (Figure 4.1). The grading system 
was a major breakthrough, as it enabled the study of prevalence and 
advancement of OA. Later, the inter- and intra-rater reliabilities of the 
technique have been evaluated to be sufficient (Gunther et al. 1999). The 
criteria for radiographically verified OA by Kellgren and Lawrence have 
been utilized in several studies which aimed to determine the prevalence of 
OA and its risk factors (Felson et al. 1987, Kellgren 1961). 
Plain radiography has long been the primary diagnostic modality 
together with the clinical examination. When judging the radiographs, 
the width of the joint space is evaluated to detect any possible narrowing. 
Furthermore, the structure of articulating bone ends is assessed in order 
to detect the presence of osteophytes and deformation or other changes in 
the subchondral bone, such as sclerosis. 
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Figure 4.1 Radiologic changes in OA process from normal joint to one with 
severe OA changes according to Kellgren and Lawrence. Radiographs by 
courtesy of Dr. Marja Pitkänen. 
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A serious problem with these commonly used diagnostic methods is 
their low sensitivity for detecting changes associated with early cartilage 
degeneration. As articular cartilage is radiolucent in conventional X-ray 
imaging, cartilage changes can be assessed only indirectly via the 
evaluation of joint space narrowing (JSN). Furthermore, the earliest 
degenerative changes cannot be detected in the physical examination, and 
they are often asymptomatic, as cartilage tissue has no innervation 
(Wooley et al. 2005). The role of radiographs has been questioned, but 
they still have important value in determining the severity of the 
progression of the disease (Cibere 2006). Furthermore, major discordance 
can exist between the radiographic OA changes and the symptoms of the 
patients (Hannan et al. 2000). No single clinical symptom or a 
combination of symptoms has been able to reliably predict radiographic 
knee OA (Claessens et al. 1990). Therefore, the plain radiographs have 
maintained their position in clinical practice and research and are useful 
when deciding about the mode of treatment. 
4.1.2  MRI 
The development of imaging modalities, such as magnetic resonance 
imaging (MRI) and computed tomography (CT) has improved the 
diagnostics of many diseases, including OA. When compared to 
radiographs, MRI permits the visualization of all components of the joint, 
including soft tissues such as articular cartilage. Furthermore, changes 
and degeneration in subchondral bone, ligaments and menisci can be 
detected. With novel high resolution MRI devices, it is possible to detect 
also minor cartilage lesions as well as alterations in other joint 
components. In clinical practice, MRI is not the primary imaging modality 
when diagnosing OA due to the associated high cost and low availability. 
However, when it is applied, typically the morphology of the cartilage is 
evaluated visually (Hayes et al. 2005). The quantitative parameters of 
cartilage MRI, which are discussed later, are mostly limited to research 
purposes.  
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4.1.3  Arthroscopy 
Articular cartilage lesions can be visually evaluated in arthroscopy. In an 
attempt to standardize the visual classification of cartilage injury, the 
International Cartilage Repair Society (ICRS) has created a visual 
classification system for grading cartilage damage during normal 
arthroscopy (ICRS Hyaline Cartilage Lesion Classification System) 
(Brittberg et al. 2003). This system classifies the damage into four grades 
depending on the lesion depth (0 Normal, 1 Nearly normal, 2 Abnormal, 
3-4 Severely abnormal) with each grade having one to four subgroups 
(Figure 4.2). An estimate of the damaged area size can also be judged. In 
addition, a manual tool is often used for subjective palpation of cartilage 
stiffness and tissue integrity. However, these measures are subjective and 
only semiquantitative at their best. Furthermore, the estimates of 
damaged area size have proven to be rather inaccurate (Oakley et al. 
2003).  
4.1.4  Ultrasonography 
Ultrasound has a long history as an imaging modality when studying soft 
tissues. Ultrasound imaging of joint structures is relatively often used in 
the treatment of patients with rheumatoid arthritis (RA). In patients 
with RA, ultrasound imaging can be used to screen joints for signs of 
disease activity, such as effusion and thickening of the synovium 
(Cimmino et al. 2008). With modern ultrasonographic appliances, also the 
small joints of the hand and feet can be evaluated (Cimmino et al. 2008). 
Visual evaluation of ultrasonographic 2D-images can be used to detect 
some typical visual features of OA (Aisen et al. 1984, Disler et al. 2000), 
and even transcutaneously in vivo (Conaghan et al. 2005, D'Agostino et 
al. 2005, Grassi et al. 2005). Again, there is no consensus about the 
usability of the method in clinical practice. 
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Figure 4.2 Images from human knee arthroscopy. 0) Normal cartilage tissue 
with smooth, intact surface (ICRS 0). 1) Cartilage with fibrillation and superficial 
lacerations (ICRS 1) 2) Abnormal cartilage sample, where the lesion extends 
deeper than the superficial layer, but less than 50% of total cartilage thickness. 3) 
Cartilage lesion, which extends through >50% of total cartilage thickness. In this 
figure, an arthroscopic probe is visible and is being used to test the lesion depth. 
4) Full-thickness osteochondral lesion, where subchondral bone is also affected 
(ICRS 4). Arthroscopic images by courtesy of Dr. Heikki Nurmi. 
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5  Novel methods for detection of early signs of 
cartilage degeneration 
5.1  Need for early OA diagnosis 
A serious hindrance for the development of early OA diagnostics is the fact 
that there is currently no curative treatment for the condition. In the case 
early OA changes could be detected, there is a lack of treatment options to 
prevent the progression of the disease. To motivate the development of 
more sensitive diagnostic tools for early OA detection, efficient treatment 
options for prevention of OA progress would also be needed. As described 
earlier, active research is being conducted e.g. to find pharmaceutical 
treatments for these indications. However, this research is at least in part 
restricted by the fact that there are no generally accepted methods for 
detection of early cartilage degeneration (Qvist et al. 2008). 
5.2  Early degenerative changes 
The earliest changes in the degenerative processes of cartilage include 
fibrillation of the superficial tissue and impairment of its mechanical 
properties. Fibrillation is a process, where the superficial collagen network 
is damaged and the integrity of superficial tissue is impaired. A decrease of 
the PG content in the superficial cartilage has been suggested to be one of 
the first detectable changes in the OA process (Buckwalter et al. 1998) and 
this leads to a decrease in the compressive stiffness. The altered mechanical 
properties make the tissue more vulnerable to further damage. The 
disruption of the superficial collagen network creates minor cracks in the 
cartilage surface, which increases the friction between the articulating 
joint surfaces. 
5.3  Indentation techniques 
The functionality of articular cartilage depends on its mechanical 
properties. Therefore, by determining these properties, important 
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information on cartilage functionality can be obtained (Knecht et al. 
2006). Several methods have been applied to determine mechanical 
properties of cartilage tissue. 
Indentation methods have been developed for the quantitative 
assessment of the mechanical properties of cartilage. For in vivo 
assessment of cartilage with these methods, at least the arthroscopic 
approach is required. Most equipment developed for this purpose is based 
on applying a predefined compression of cartilage surface mechanically 
with an instrument and then making a simultaneous measurement of the 
applied forces (Appleyard et al. 2001, Lyyra et al. 1995, Niederauer et al. 
2004). The force by which cartilage resists deformation is regarded as an 
index for structural stiffness. The thickness of cartilage cannot be 
evaluated with conventional indentation devices even though the 
thickness is known to affect the indentation response of cartilage. 
Therefore, the determined stiffness values include some error, as the 
variation in tissue thickness is not taken into account (Hayes et al. 1972). 
Furthermore, it is considered that these methods gather information 
mostly from the superficial layer of cartilage (Korhonen et al. 2002b). 
Challenges in obtaining reproducible localization and orientation of the 
indentation have also restricted the spread of the method into wider 
clinical use. 
5.4  Ultrasound and mechano-acoustic methods 
To overcome the restrictions of plain mechanical indentation, our research 
group has further developed a commercial indentation instrument 
(Artscan 200, Artscan Oy, Helsinki, Finland) by equipping it with a 
miniature ultrasound transducer. In the ultrasound indentation, the 
cartilage surface is compressed with a flat miniature ultrasound 
transducer. Ultrasound signal is reflected from the bone-cartilage interface 
and by determining the time that the ultrasound signal takes to travel 
through-and-back out of the cartilage during indentation testing, it is 
possible to determine the original cartilage thickness as well as the applied 
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strain. The in-built force gauge is used to determine the applied 
compressive force. In response to dynamic loading, i.e. under high rate 
and small strain compression, cartilage can be modeled as a linearly elastic 
material. Therefore, it is possible to calculate the elastic modulus for the 
cartilage (Hayes et al. 1972). Different approaches, such as a water-jet 
system, have also been introduced for the same purpose (Duda et al. 2004, 
Lu et al. 2005, Lu et al. 2009). In these techniques, the tissue thickness 
and deformation under load are determined by ultrasound time-of-flight 
technique. However, recent publications suggest that ultrasound speed in 
cartilage may change during compression (Nieminen et al. 2006). This can 
induce significant errors in the determined thickness, deformation and 
mechanical modulus values (Nieminen et al. 2007). 
5.5  Ultrasonography and quantitative ultrasound parameters 
Ultrasound speed has been suggested to be a sensitive measure for 
assessing cartilage pathology, and its measurement might help in 
diagnosing early OA changes (Suh et al. 2001, Töyräs et al. 2003). The 
ultrasound echo from the cartilage surface reflects surface roughness and 
tissue integrity (Adler et al. 1992, Cherin et al. 1998, Chiang et al. 1994, 
Disler et al. 2000, Nieminen et al. 2002, Saied et al. 1997, Töyräs et al. 
1999). Later, quantitative methods for the surface analysis have been 
developed (Saarakkala et al. 2004). In the simplest approach, the 
ultrasound reflection from the cartilage surface can be quantified during 
point-like measurements (Chérin et al. 1998, Saarakkala et al. 2004). 2D-
imaging of cartilage surface makes it possible to calculate quantitative 
parameters describing the roughness of the cartilage surface (Saarakkala et 
al. 2004). As ultrasound is able to penetrate the cartilage tissue, tissue 
thickness can also be determined and alterations in subchondral bone and 
in the internal structure of cartilage may be detected (Laasanen et al. 
2003, Laasanen et al. 2006, Saarakkala et al. 2006). The presented 
methods require that the ultrasound transducer is in close contact with 
the cartilage surface and therefore at least a minimally invasive approach 
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is required, e.g. during arthroscopic surgery. The reason for this is that 
high-frequency ultrasound has limited penetration properties in tissues. 
Although some of the presented methods might also be suitable for a 
transcutaneous approach, the anatomy of the knee joint does not allow 
imaging of all joint surfaces. A novel method for 2D-imaging of intra-
articular structures is the application of minimally invasive intra 
articular-ultrasound imaging of articular cartilage, which is analogous to 
intravenous ultrasound imaging (Viren et al. 2009). 
5.6  Quantitative MRI 
Today, MRI is typically used for imaging purposes, however, modern MRI 
appliances for both research and clinical use are capable of determining 
tissue-specific quantitative parameters. In the quantitative analysis of 
cartilage, several magnetic resonance parameters have been developed 
(Blumenkrantz et al. 2007, Burstein et al. 2003, Conaghan 2006, Gray et 
al. 2004). The T2 relaxation time of cartilage has been shown to reflect the 
structure and integrity of collagen fibril architecture of articular cartilage 
and the OA severity (Dunn et al. 2004, Nieminen et al. 2000). The depth-
wise differences in T2 values of cartilage have been attributed to the 
properties of intrinsic water in the tissue and the interactions of water 
molecules with the collagen network of the tissue (Rubenstein et al. 1993). 
Furthermore, the technique of measuring T1 relaxation of cartilage in the 
presence of a gadolinium contrast agent (delayed gadolinium enhanced 
magnetic resonance imaging of cartilage, dGEMRIC) is used for 
determining the relative proteoglycan content of cartilage. The 
paramagnetic contrast agent gadolinium strongly shortens the T1 
relaxation of cartilage. The negatively charged Gd-DTPA2- is thought to 
distribute in cartilage in an inverse manner to the proteoglycan 
concentration of the tissue. Therefore, the T1 relaxation in the presence of 
gadolinium has been shown to associate with the PG content of the tissue 
in vitro (Bashir et al. 1996, Bashir et al. 1999, Blumenkrantz et al. 2007, 
Gray et al. 2001). Other MRI techniques have also been presented for 
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quantitative assessment of articular cartilage. The T1rho relaxation time has 
also been shown to reflect the PG content and distribution within 
cartilage (Akella et al. 2001). Diffusion imaging (Filidoro et al. 2005), 
magnetization transfer (Gray et al. 1995) and 23Na-MRI techniques (Insko 
et al. 1999) have also been claimed to offer non-invasive assessment of 
articular cartilage. Novel GAG-targeted contrast agents are also being 
developed to improve cartilage evaluation (Winalski et al. 2008). 
Furthermore, the magnetic resonance imaging can be used to quantify 
cartilage morphology, such as cartilage volume or thickness (Eckstein et al. 
1994, Eckstein et al. 2005, Peterfy et al. 1994), and therefore repetitive 
scans can be used to monitor progression of the disease (Raynauld et al. 
2004). However, a recent study on volumetric evaluation of cartilage using 
MRI suggests that the method is not sensitive enough to identify early OA 
changes (Reichenbach et al. 2009). 
5.7  Other methods  
Several other biophysical methods have been developed for detecting OA 
changes in cartilage. These include optical coherence tomography (OCT) 
(Adams et al. 2006, Herrmann et al. 1999, Pan et al. 2003, Xie et al. 2006, 
Xie et al. 2008), contrast agent enhanced computerized tomography (CT) 
(Kallioniemi et al. 2007, Piscaer et al. 2008, Silvast et al. 2009a, Silvast et 
al. 2009b, Xie et al. 2009), atomic force microscopy (Stolz et al. 2004), 
confocal microscopy (Chiang et al. 1997), contact and laser profilometry 
(Forster et al. 1999), spectroscopy (Spahn et al. 2007), and determination 
of streaming potentials within cartilage tissue during arthoscopy (Garon 
et al. 2002, Legare et al. 2002). Even radiographic techniques, using 
synchrotron sources of X-rays, have been able to visualize articular 
cartilage, thus potentially providing valuable information for evaluating 
also early OA changes in cartilage (Muehleman et al. 2004a, Muehleman et 
al. 2004b). 
Several biochemical biomarkers or their combinations have also been 
proposed to serve as diagnostic tools for OA (Davis et al. 2007). Some 
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biomarkers have been suggested to serve as prognostic tools (Garnero 
2002). The basic concept behind most biomarkers is that the metabolites 
resulting from the cartilage degradation, attempts at cartilage repair, 
increased cartilage or bone remodeling and turnover or synovial 
inflammation, can be detected from serum, urine or synovial fluid (Davis 
et al. 2007, Garnero et al. 2000, Lohmander et al. 2003). It has been 
suggested that as the biomarkers arise from a variety of sources, it would 
be useful to clarify the sources of the biomarkers. Different categories of 
biomarkers could be used as prognostic, diagnostic or investigative tools. 
Furthermore, the efficacy of therapeutic intervention and total burden of 
the disease could be assessed by monitoring changes in specific biomarker 
patterns (Bauer et al. 2006). However, the currently available biomarkers 
are not sensitive enough to be used as disease-activity or progression 
markers of OA (Kraus 2006). 
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6  Aims of the present study 
The function of cartilage tissue is dependent on the composition and 
structure of the tissue. Therefore, understanding the structure-function 
relationships is essential for the development of efficient diagnostics of 
OA. Furthermore, several quantitative biophysical methods have been 
introduced for the detection of cartilage degeneration, but comparative 
data between these methods is scarce. The specific aims of this study were: 
 
1. to characterize the structural components that play key roles in 
determining the Poisson’s ratio of cartilage. 
 
2. to compare MRI, ultrasound and mechanical methods in evaluating 
degenerative changes in cartilage. 
 
3. to clarify the extent of site-dependent variations in the mechanical, 
compositional and structural properties of the patellar cartilage surface 
and how these properties are affected by the OA process. 
 
4. to investigate the effect of the spatial variation of tissue properties on 
the early OA diagnostics and to compare arthroscopically applicable 
methods in this regard. 
 
5. to investigate how changes in the ultrasound speed in cartilage during 
compression influence the reliability of ultrasound indentation 
measurements. 
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7  Materials and methods 
7.1  Tissue specimens and sample preparation 
This study was carried out in situ and in vitro. A brief overview of the 
materials and methods of the studies I-IV is presented in Table 7.1. 
Bovine tissue was used in studies I and II, whereas human cartilage tissue 
was investigated in studies III and IV. Bovine tissue samples were 
obtained from a local slaughterhouse. Knee and shoulder joints with 
intact joint capsules were dissected and delivered within a few hours post 
mortem. In study I, osteochondral samples were prepared from the patella, 
medial femoral condyle, medial tibial plateau and humeral head. Only 
visually healthy tissue was utilized in this study. In study II, the samples 
were prepared from the lateral facets of bovine patellae. In this study, the 
material included samples with visual signs of degeneration, in addition 
to samples with a healthy appearance. In both studies, the samples were 
frozen after initial preparation and thawed before the measurements.  
Human patellae for studies III and IV were collected from right knee 
joints of 14 cadavers at autopsy in Jyväskylä Central Hospital within 48 
hours postmortem. The collection and use of human tissue was conducted 
with the permission from the National Agency of Medicolegal Affairs in 
Finland (Permission n:o 1781/32/200/01). Knee joints were opened, the 
patellae were dissected free and frozen separately for later use. From the 
patellar cartilage surface, six anatomically defined measurement locations 
were identified on the patellar cartilage surface using a marker without 
harming the points of interest. 
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Table 7.1 Materials and methods utilized in the thesis work 
Study # I II III IV 
n 30 32 84/75/73 73 
Species Bovine Bovine Human Human 
Location HUM, MFC,  
MTP, PAT 
PAT PAT PAT 
Testing 
method 
Mechanical testing  
   -EEQ 
   -Poisson’s ratio 
MRI 
   -dGEMRIC 
   -T2 
US indentation 
   -EUS 
   -RUS,  
Ultrasound 
   -URI 
   -IRC 
   -speed 
   -attenuation 
Indentation 
   -FIND 
US indentation  
   -EUS 
   -RUS,  
 
Ultrasound 
   -speed 
   -attenuation 
   -changes during   
    compression 
Reference 
methods 
Microscopy 
   -ePLM 
   -OD 
       -PGs 
   -FTIRI 
      -Collagen 
   -Mankin score 
Microscopy 
    -Mankin score 
Water content 
Biochemistry 
   -Collagen 
   -PGs 
Mechanical testing 
   -EEQ 
   -EDYN 
Microscopy 
   -OD 
       -PGs 
   -FTIRI 
       -Collagen 
   -OA grade 
Mechanical testing 
   -EEQ 
   -EDYN 
Microscopy 
   -OD 
       -PGs 
   -FTIRI 
       -Collagen 
   -OA grade 
Mechanical testing 
   -EEQ 
   -EDYN  
Water content 
PAT: patella; MFC: medial femoral condyle; HUM: humeral head; MTP: medial 
tibial plateau. 
7.2  Novel diagnostic techniques 
7.2.1  Indentation techniques 
In study III, a modification of commericially available indentation 
instrument (Artscan 200, Artscan Oy, Helsinki, Finland) was used for 
testing of human patellar cartilage in situ (Figure 7.2 a). Six 
measurement locations were selected on the patellar cartilage surface 
(Figure 7.1) and the indentation measurements were conducted using 
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the instrument with a small semi-spherical indenter (diameter 0.5 mm) 
(Töyräs et al. 2001). The force by which the cartilage resists the 
compression was used as an index for cartilage stiffness. Two independent 
sets of compressions were performed and four compressions from each set 
were averaged for analysis. 
7.2.2  Mechano-acoustic techniques 
The mechano-acoustic indentation device is the result of further 
development of the mechanical indentation instrument (Laasanen et al. 
2002). It has a miniature ultrasound transducer (ø=3mm, f=10MHz) 
mounted on the tip of the instrument. This flat transducer is used to 
compress articular cartilage (Figure 7.2 b). The reflected ultrasound 
signal from the cartilage-bone interface is measured to determine tissue 
thickness using the time-of-flight method. Cartilage tissue was compressed 
with the instrument at six measurement locations on the patellar cartilage 
(Figure 7.1). The measurement device was first placed on the cartilage 
surface. In order to determine cartilage thickness reliably, it was 
important to keep the indenter perpendicular to the cartilage surface and 
the underlying subchondral bone, from where the ultrasound echo is 
reflected. This was ensured by following the ultrasound signal during the 
compression test. By using a predefined contact stress, the cartilage 
thickness was determined by using the time-of-flight method. The 
controller software calculated the cartilage thickness during the 
compression test, and compressions of 5% of the original thickness of the 
tissue were performed. During testing, the applied strain and the reaction 
force were determined. These parameters were then used to calculate the 
dynamic tissue modulus. Furthermore, the same instrument was used to 
determine the ultrasound reflection coefficient of cartilage surface. First, a 
plastic sleeve was attached to the miniature ultrasound transducer of the 
device to maintain a constant distance between the cartilage surface and 
the ultrasound transducer (Figure 7.2 c). Then, the device was placed on 
the cartilage, and the maximum peak-to-peak echo amplitude was 
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measured for calculation of the ultrasound reflection coefficient of the 
cartilage surface (RUS). The mechanical measurements were performed 
without the external sleeve. 
 
 
Figure 7.1 Measurement locations on human patellar cartilage surface in studies 
III and IV. 1 Superomedial, 2 Central medial, 3 Inferomedial, 4 Superolateral, 5 
Central lateral and 6 Inferolateral 
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Figure 7.2 Schematic presentation of the mechanical indentation measurement 
(A), ultrasound indentation measurement (B) and measurement of RUS(C). The 
mechanical reference measurements were carried out with a mechano-acoustic 
material testing device in unconfined geometry in all studies (D). Ultrasound speed 
and attenuation were determined during mechanical reference testing in studies II 
and IV (E).  
7.2.3  Ultrasound techniques 
The measurements of IRC, URI and R in study II were performed by 
scanning the samples with a commercially available quantitative 
ultrasound-imaging unit (Dermascan-C, Cortex Technology, Hadsund, 
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Denmark) (Saarakkala et al. 2006). Briefly, the ultrasound signal was 
recorded for analysis of reflection coefficient in the time-domain (R, %) 
and frequency-dependent integrated reflection coefficient in the frequency 
domain (IRC, dB). The ultrasound roughness index (URI, µm) was 
determined from the ultrasonically determined surface contour profile. 
7.2.4  MRI techniques 
In study II, quantitative MRI was performed on bovine samples (Nissi et 
al. 2004). The measurements were conducted using a 9.4 T research MRI 
device (Oxford Instruments Plc, Witney, UK). In study II, for comparison 
with other parameters, we determined the T2 relaxation times of superficial 
cartilage and the bulk dGEMRIC value (T1 relaxation time in presence of 
Gd-DTPA2- contrast agent. 
7.3  Reference methods 
7.3.1  Mechano-acoustic measurements 
Biomechanical testing of cartilage samples was carried out in all studies. 
The testing was conducted using a custom-built mechano-acoustic high-
resolution material testing device (Figure 7.2 d) (Laasanen et al. 2002). 
The cartilage discs were tested in unconfined compression geometry 
(Figure 7.2 e). During the measurements, the ultrasound signal was 
collected and analyzed (studies II and IV). The ultrasound speed was 
analyzed with the time-of-flight method. Ultrasound attenuation was 
determined as described earlier (Nieminen et al. 2004). 
7.3.2  Histological grading of articular cartilage structure 
After mechanical testing of the samples, the tissue specimens were 
immersed in 10% formalin solution for fixation. The tissue was then 
further processed and embedded in paraffin to enable preparation of 
histological sections. 
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In study II, the histological integrity of the samples was determined by 
using the histological-histochemical grading system (HHGS, also known as 
Mankin Scoring or Mankin System) introduced by Mankin et al. (1971). 
In light microscopy, the histological integrity of cartilage was graded 
using the Safranin-O stained histological sections. Tissue structure, 
cellularity and Safranin-O stainability of the samples and the integrity of 
the tidemark were visually evaluated (Table 7.2).  
The value of this method has been questioned, as its reproducibility 
has been shown to be low (Ostergaard 1997, 1999). To improve the 
histological grading, Osteoarthritis Research Society International 
(OARSI) established a working group to create a novel grading method 
for OA changes in cartilage. This method was introduced in 2006 (Pritzker 
et al. 2006). In studies III-IV, the OARSI OA grading was used to 
evaluate the cartilage integrity (Table 7.3). 
Table 7.2 Histological-histochemical grading system (Mankin scoring) 
Grade Grade 
I. Structure 
 a. Normal 
 b.  Surface irregularities 
 c.  Pannus and surface irregularities 
 d. Clefts to transitional zone 
 e. Clefts to radial zone 
 f. Clefts to calcified zone 
 g. Complete disorganization 
II. Cells 
 a. Normal 
 b. Diffuse hypercellularity 
 c. Cloning 
 d. Hypocellularity 
 
0 
1 
2 
3 
4 
5 
6 
 
0 
1 
2 
3 
III. Safranin-O staining 
 a. Normal 
 b. Slight reduction 
 c. Moderate reduction 
 d. Severe reduction 
 e. No dye noted 
 
 
 
 
IV. Tidemark integrity 
 a. Intact 
 b. Crossed by blood vessels 
 
0 
1 
2 
3 
4 
 
 
 
 
 
0 
1 
(Mankin et al. 1971) 
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Table 7.3 OARSI cartilage histopathology grade assessment – grading 
methodology 
Grade 0: surface intact, cartilage morphology intact 
Grade 1: surface intact 
Grade 2: surface discontinuity 
Grade 3: vertical fissures (clefts) 
Grade 4: erosion 
Grade 5: denudation 
Grade 6. deformation 
(Pritzker et al. 2006) 
 
 
 
 
Figure 7.3 Characteristic cartilage sections with different stages of degeneration. 
Cartilage surface is smooth in healthy cartilage and the cartilage tissue stains 
intensely with Safranin-O. During the degenerative process, the Safranin-O 
staining decreases as a sign of PG depletion and the cartilage surface undergoes 
fissuration and cleft formation. 
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7.3.3  Optical density (OD) measurements 
One typical feature of the OA process is the decrease in the PG content of 
the cartilage tissue. Optical density measurements can be used to evaluate 
the PG content and distribution of cartilage. The histological sections 
were stained with cationic Safranin-O stain, which targets the anionic 
sulphate and carboxyl groups derived mainly from the PGs of the tissue 
(Király et al. 1996). The PG content could then be evaluated by the 
measurement of absorbance of monochromatic light in the sample with a 
calibrated densitometer system with Leitz Ortholux II microscope (Leitz 
Wetzlar, Wetzlar, Germany) and a cooled 12-bit CCD camera 
(Photometrics, Tucson, AZ, USA). This semiquantitative method was 
used for determination of tissue PG content in studies I and III. 
Furthermore, the spatial distribution profiles of PGs were determined and 
included when the mechanical behavior of the samples in studies I and IV 
were modeled.  
 
 
Figure 7.4 Characteristic images from optical density, FTIRI collagen and 
orientation analyses in normal human patellar cartilage. 
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7.3.4  Fourier transform infrared imaging (FTIRI) 
Infrared spectroscopy has been used to characterize and analyze various 
chemical components from various samples for long time. The Fourier 
transform infrared imaging (FTIRI) technique was used to map the 
infrared absorption spectra from unstained tissue sections with a 
resolution from 6.25 to 25 µm by using PerkinElmer Spotlight 300 
instrument (Perkin Elmer, Waltham, MA, USA). Calculation of specific 
parameters from the spectrum at each pixel of the sample made it possible 
to create images which illustrate the spatial distribution of selected 
macromolecules (Camacho et al. 2001, Potter et al. 2001). In studies I, III 
and IV, FTIRI was utilized to estimate the collagen content and the 
spatial distribution of collagen in the samples by calculating the 
integrated absorption of the amide I peak (wave numbers 1610-1710 
1/µm) in each pixel of the tissue sections. Thereafter, the absorption 
values of each pixel row were averaged horizontally to create a depth-wise 
collagen content profile of the samples. The averaged value of the profile 
was considered to represent an estimate of the total collagen content of the 
sample. 
7.3.5  Enhanced polarized light microscopy (ePLM) 
Collagen is a birefringent material and can rotate the plane of polarized 
light. Therefore, polarized light microscopy can be used to specifically 
analyze the structure and deposition of collagen in articular cartilage. The 
methods related to enhanced polarized light microscopy (ePLM) have been 
described thoroughly in a recent article (Rieppo et al. 2008).  Briefly, the 
unstained cartilage sections were analyzed with a computer-controlled 
semi-automated polarized light microscope system built around scientific 
grade polarized light microscope (Leitz Ortholux II POL, Leitz-Wetzlar, 
Wetzlar, Germany). After alignment of the polarizer pair of the system, a 
series of images was acquired with different positions of the polarizer pairs 
to collect all signals from the birefringent sample. The acquired images 
were processed with custom-made software. As the signal intensity in each 
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pixel follows a sinusoidal function determined by the polarizer alignment 
angle and the birefringent behavior of the collagen fibrils, the theoretical 
maximal and minimal signal intensities can be determined through a least 
square fitting method. The orientation-independent birefringence was 
determined as the theoretical maximum signal intensity. Anisotropy, or 
the degree of parallelism is an index to measure the parallel alignment of 
the collagen fibrils in each pixel of the sample. This was determined by the 
ratio of minimal to maximal signal intensities (Rieppo et al. 2008). The 
Stokes parameters were determined to determine orientation of collagen 
fibrils and the mean orientation of collagen fibrils was calculated by using 
these parameters in each pixel of the section (Collett 1992). In study I, the 
birefringence, orientation of the collagen fibrils and anisotropy maps of 
the samples were analyzed and the obtained depth-wise profiles were 
processed similarly as the results from the OD and FTIRI measurements. 
7.3.6  Biochemical analyses 
In study II, biochemical analyses were conducted to determine the 
proteoglycan and collagen contents of the samples. A detailed description 
of the measurements has been described earlier (Töyräs et al. 2003). 
Briefly, the PG content was determined using a spectrophotometric assay 
of the uronic acid content (Blumenkrantz et al. 1973). The collagen 
content was quantified by assaying the hydroxyproline content of the 
samples (Schwartz et al. 1985). In studies II and IV, the interstitial water 
fraction was measured from the ratio of the wet and dry weights for each 
sample. 
7.4  Numerical modeling of cartilage mechanics 
In study I, finite element (FE) analyses were performed to determine the 
specific role of the PGs and collagen network on the Poisson’s ratio. For 
this purpose, an axisymmetric fibril-reinforced poroelastic model was 
created as detailed in study I. Quadratic 8-node continuum elements were 
created to mimic the PG matrix and interstitial fluid, whereas horizontal 
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spring elements represented the collagen network. The Poisson’s ratio of 
PG matrix was set to 0.42 and the effect of PG matrix and collagen fibril 
moduli values on the cartilage Poisson’s ratio was studied at equilibrium. 
7.5  Statistical analyses 
Correlation coefficients between continuous variables were calculated as 
Pearson correlation coefficients. Spearman’s Rho was calculated for the 
correlation analysis with discrete parameters such as OARSI OA-grade 
and Mankin score (Blalock 1972). Kruskal-Wallis-H-test was used to 
determine the statistical significance of the site-dependent variation of the 
parameters in study I as well as the significance of the differences between 
different degeneration groups in study II. Furthermore, in study II, the 
Mann-Whitney U-test was utilized to test statistical significance when 
comparing the healthy samples with the degenerated samples. 
In studies III and IV, the linear mixed model was used to determine 
differences between the sample groups. This test was selected, as it enabled 
the comparison of samples with possible interdependencies (Brown et al. 
2006). Thereby, the potential interrelationships between the samples from 
the same individual, or from the same location, were taken into account. 
In studies II and III, the receiver operating characteristic (ROC)-
analysis was conducted to determine optimal cut-off values for the 
diagnostic variables. The selection was based on finding the point of the 
ROC-curve where the sum of sensitivity and specificity was maximal. 
All statistical analyses were conducted using SPSS statistical software, 
versions 11.0.2-16.0.2 (SPSS inc., Chicago, IL, USA). 
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8  Results 
8.1  Structure-function relationships in cartilage 
In study I, the value of equilibrium modulus was found to be primarily 
determined by the PG content of cartilage (Table 8.1). The Poisson’s 
ratio values were primarily determined by the collagen content and the 
orientation of the collagen network (Table 8.1). This result was also 
confirmed by the FE model, which indicated that the effect of PG matrix 
on the Poisson’s ratio of cartilage was less significant than the effect of 
collagen network (Figure 8.1). The structure of collagen network in 
patellar cartilage was often found to differ from the typical three-layered 
structure, as analyzed by the ePLM measurements. Several samples 
demonstrated an extra lamina in the middle cartilage layer where the 
collagen fibrils were oriented in parallel to the surface (Figure 4 in Study 
I). 
 
Figure 8.1 According to the FE-model, the effect of collagen fibril network 
modulus on Poisson’s ratio is stronger than that of the PG matrix modulus. 
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Table 8.1 Linear correlation coefficients between the mechanical and the 
structural parameters of bovine knee and humeral articular cartilage (n=30). 
ePLM  
PGs Collagen Birefringence Orientation Anisotropy 
EEQ 0.86 * 0.72 * -0.53 * -0.10 0.14 
Poisson's 
ratio 
-0.33 -0.59 * 0.15 0.36 * 0.03 
* p<0.05  
8.2  Topographical variation in properties of cartilage 
In study I, the mechanical properties, i.e. equilibrium modulus and 
Poisson’s ratio of cartilage displayed a site-dependent variation between 
different measurement sites (p<0.05) (Table 1 in Study I). Further, the 
results from studies III and IV displayed significant site-dependent 
variation (p<0.05) in mechanical, compositional and acoustic parameters 
within patellar cartilage surface (Figure 3 in Study III and Figure 3 in 
Study IV). However, in contrast to all other parameters, ultrasound 
reflection from the cartilage surface exhibited no statistically significant 
topographical variations in healthy cartilage (p=0.61). 
8.3  Detection of cartilage degeneration 
The results from MRI, ultrasound indentation and 2D ultrasound 
measurements revealed a statistically significant variation between the 
healthy and degenerated samples (p<0.05) (Study II). Values of Mankin 
score were not significantly different between the samples with normal 
visual appearance or with early degenerative changes, such as slighty 
discolored surface (Figure 4 in Study II). ROC analysis enabled 
comparison of the specificity and sensitivity between different methods. 
The relatively low number of samples prevented the comparison of the 
methods using the AUC (area under the curve) analysis. However, several 
methods showed promising specificity and sensitivity values. When 
comparing the diagnostic parameters with each other, the ultrasound 
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parameters (RUS, URI, IRC) showed the highest sensitivity and specificity 
values, whereas MRI parameters demonstrated lower values from 0.67-0.81 
(Table 8.2). Furthermore, most of the measured variables showed high 
correlations with the mechanical and compositional reference parameters 
(Table 8.3). The best predictors of the histological integrity were R, URI 
and IRC, r=0.84-0.85. Ultrasound indentation (Edyn) showed the 
strongest association with the reference mechanical parameters (Table 
8.3).  
Table 8.2 Mean (± SD), cut-off, specificity and sensitivity values of cartilage 
samples categorized by Mankin scoring (0, 1-3, >3). The biophysical methods 
revealed statistically significant variation between the different levels of 
degeneration. Furthermore, after determination of an optimal cut-off value for 
each method (ROC analysis) to detect degenerated samples, good specificity and 
sensitivity values were revealed for several methods. 
Mankin score  
0 
(n =11) 
1-3 
(n =11) 
3- 
(n =10) 
Cut-
off 
Speci-
ficity 
Sensi-
tivity 
Ultrasound 
indentation 
      
Edyn (MPa)* 9.1 ± 6.1 3.7 ± 3.6 1.5 ± 0.5 2.5 0.89 0.71 
RUS(%)* 3.7 ± 1.2 1.9 ± 1.1 0.6 ± 0.3 2.3 0.89 0.91 
MRI       
T2 (ms)* 43 ± 14 69 ± 59 120 ± 105 44 0.67 0.81 
T1GD (ms)* 401 ± 4 371 ± 35 322 ± 64 386 0.67 0.81 
Ultrasound       
α (dB/mm)* 2.65 ± 0.58 2.01 ± 0.45 1.76 ± 0.43 2.50 0.78 0.95 
SOS (m/s)* 1603 ±27 1572 ± 15 1548 ± 14 1576 0.78 0.91 
IRC (dB)* -26.7 ± 1.6 -30.9 ± 4.0 -37.6 ± 4.6 -29.0 0.91 0.86 
URI (µm) * 7.4 ± 1.2 15.1 ± 8.5 34.3 ± 15.4 10.2 1.00 0.91 
*p<0.01 
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Table 8.3 The biophysical parameters revealed strong correlations with the 
reference parameters. Correlation with Mankin scores was highest for R and for 
IRC and URI (r=0.84), as measured with the 2D ultrasound imaging device. The 
best predictor of mechanical properties was Edyn, as measured with the ultrasound 
indentation instrument. Furthermore, the speed of sound was strongly associated 
with Edyn,ref and Eref. 
 Mankin 
score 
PG 
content 
Collagen 
content 
Water 
content 
Eref Edyn,ref Average 
r 
Edyn -0.73** 0.87** 0.86** -0.69** 0.60** 0.98** 0.79 
RUS -0.85** 0.83** 0.78** -0.66** 0.58** 0.87** 0.76 
α -0.55** 0.65** 0.64** -0.65** 0.47** 0.62** 0.60 
SOS -0.76** 0.90** 0.86** -0.80** 0.79** 0.90** 0.83 
T2 0.61** -0.36* -0.33 0.34 -0.33 -0.30 0.37 
T1Gd -0.54** 0.62* 0.36 -0.56** 0.63** 0.50** 0.54 
IRC -0.84** 0.61** 0.54** -0.48** 0.58** 0.58** 0.61 
URI 0.84** -0.49** -0.49** 0.37* -0.49** -0.48** 0.53 
*p<0.05, **p<0.01, n=30-32. 
 
The results from study III indicate that both ultrasound indentation 
and mechanical indentation measurements reflect the true mechanical 
properties of the tissue (Figure 8.2 a-b). Furthermore, both these 
measurements are significantly correlated with the collagen content of the 
samples (Figure 8.2 c-d). The ultrasound reflection from the healthy 
cartilage surface showed no statistically significant (p=0.61) 
topographical variation. This was the only parameter which exhibited any 
statistically significant difference (p=0.01) between the healthy samples 
and samples with signs of early degeneration (Table 8.4). 
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Table 8.4 Values of measured parameters (Mean ± SD) among samples divided 
into groups with variable cartilage degeneration: Healthy cartilage (OARSI OA 
Grade 0), Early degeneration (Grades 1.0-1.5), Advanced degeneration (Grades 
2 and above). RUS was the only parameter that showed any statistically 
significant difference between the healthy samples and the samples with early 
degeneration. 
 Healthy 
cartilage 
n=35 
Early 
degeneration 
n=17-18 
Advanced 
degeneration 
n=21-22 
All samples 
n=73-75 
      [————— p<0.001 —————] 
      [— p=0.01 —]     [— p<0.001—] 
RUS (%) 2.34 ± 0.74 1.79 ± 0.74 0.80 ± 0.80 1.76±1.00 
       
EUS (MPa) 3.51± 1.67 3.88 ± 2.08 2.64 ± 1.98 3.34±1.90 
      [————— p<0.001 —————] 
         [— p=0.004 —] 
FIND (N) 0.41 ± 0.18 0.40 ± 0.18 0.23 ± 0.16 0.36±0.19 
      [————— p<0.001 —————] 
        [— p<0.001 —] 
EDYN (MPa) 4.67±2.24 4.76±3.01 1.87±2.32 3.88±2.75 
      [————— p<0.001 —————] 
        [— p<0.001 —] 
EEQ (MPa) 0.64±0.30 0.70±0.62 0.21±0.26 0.53±0.44 
      [————— p<0.001 —————] 
        [— p<0.001 —] 
PG content 
(absorbance) 
1.36±0.29 1.19±0.32 0.83±0.37 1.16±0.39 
      [————— p<0.001 —————] 
        [— p<0.001 —] Collagen content 
(absorbance) 0.25±0.03 0.25±0.05 0.21+0.03 0.24±0.04 
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8.4  Ultrasound speed and attenuation in healthy and 
degenerated patellar cartilage 
In study IV, values ultrasound speed and attenuation showed a 
statistically significant spatial variation in patellar cartilage surface in all 
samples as well as when only healthy samples were analyzed (Figure 3 in 
Study IV). The values of ultrasound speed were typically between 1560 
m/s and 1640 m/s (Figure 8.3 a), i.e. the average variation was less than 
5 %.  
Ultrasound speed associated significantly with the compositional and 
mechanical parameters of the cartilage tissue (Table 8.5). Ultrasound 
speed and reference dynamic modulus displayed a strong positive 
correlation (r=0.81, n=67, p<0.01). Partial correlation analysis revealed 
that the water and collagen contents were individual determinants of the 
ultrasound speed. The water, collagen and PG contents of the tissue were 
able to explain 55% of the variation in the ultrasound speed between the 
samples, whereas the compositional properties accounted for 69% and 67 
% of the variation in the equilibrium modulus and dynamic modulus of 
the tissue, respectively. 
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Figure 8.2 Scatter plots of the indentation measurements and the reference 
mechanical modulus and collagen content. Ultrasound indentation results 
displayed a linear positive correlation (p<0.01) with both mechanical indentation 
and reference dynamic modulus. When the samples with different grades of 
degeneration were averaged at each location, the indentation results showed a 
significant (p<0.01) positive correlation with the collagen content of the samples. 
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Table 8.5 Linear correlations and partial correlations between the ultrasound 
and reference parameters 
 OARSI 
OA-grade 
Water 
content 
Collagen 
content 
PG 
content 
EEQ EDYN 
SOS -0.30* -0.57** 0.70** 0.44** 0.74** 0.81** 
ΔSOS 0.07 0.25* -0.37** -0.16 -0.36* -0.39** 
α 0.18 -0.23 0.31* -0.003 0.08 0.17 
Δα  0.41** 0.43** -0.71** -0.36** -0.68** -0.68 
Partial 
correlations 
 Water 
content 
Collagen 
content 
PG 
content 
R2  
SOS  -0.32** 0.52** 0.09 0.55**  
ΔSOS  0.08 -0.29* 0.05 0.14*  
α  -0.12 0.29* -0.21 0.14*  
Δα  0.10 -0.59** 0.01 0.50**  
EEQ  -0.26* 0.48** 0.56** 0.69**  
EDYN   -0.45** 0.45** 0.38** 0.67**  
n=67-68, *p<0.05, **p<0.01 
8.5  Compression induced variation of ultrasound speed 
Both ultrasound speed and attenuation typically decreased during 
compression. The decrease in ultrasound speed during compression was 
low, being under 2% on average. However, this variation was estimated to 
cause errors of up to 15 % in the values of mechanical modulus of articular 
cartilage, as determined by ultrasound indentation (Figure 8.3 c). 
Interestingly, the magnitude of error was greatest in those samples with 
early degenerative changes. In the degenerated tissue, the change in 
ultrasound speed was minimal (Figure 8.3 b). 
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Figure 8.3 Topographical variation of ultrasound speed in human patellar 
cartilage (A). Change in speed of sound during 2% compression (B). The errors 
that arise due to the assumption that there is a constant ultrasound speed in 
cartilage and the ultrasound speed change during compression (C). 
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9  Discussion  
OA is a common disease with major economical and sociological 
consequences. At present, the treatment is mostly symptomatic, focusing 
on attempts to decrease the pain of the diseased joints. This palliative 
treatment is far from satisfactory, but at present there are no therapies 
available for preventing the progression of the disease. 
OA is known to impair the structural, compositional and mechanical 
properties of cartilage. The earliest changes involve a deterioration of the 
superficial collagen network and a decline in the superficial PG 
concentration. These changes have been postulated to take place even 
before visual changes occur on cartilage surface. Fibrillation of the 
cartilage surface is the first visible change which can be observed during 
arthroscopy. This process is followed by a further reduction of the PGs, 
and an increase in the water content of cartilage and these compositional 
changes make cartilage softer. As the fibrillation continues, cartilage starts 
slowly eroding and the end stage of this disease is the denudation of 
articulating bone end. 
Today, the diagnosis of OA is usually based on the combination of 
clinical examination with conventional radiographs. By using the 
traditional X-rays, it is possible to evaluate the cartilage changes only 
indirectly by joint space narrowing, a sign of advanced disease, when a 
substantial amount of cartilage has worn away (Hayes et al. 2005). Bone-
associated changes such as osteophyte formation, subchondral sclerosis 
and cyst formation are also typical features associated with the advanced 
disease. 
Several therapeutic approaches, mostly pharmaceuticals, are under 
development for the prevention of OA progression. Furthermore, several 
cartilage repair techniques for treating local cartilage defects are being 
developed. Many of the methods are in the pre-clinical phase and being 
tested in laboratory animals. In these situations, the results of precise 
histological analysis can be evaluated. However, to prove the efficacy of 
these methods in clinical trials, it is crucial to have sensitive quantitative 
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methods for assessing the outcome of the treatment. Radiographs are far 
too insensitive to allow detection of the early OA changes. If these were to 
be used, however, the follow-up time would have to be very long and the 
number of patients would have to be very high. In one clinical study 
where these kinds of follow-up methods were selected, a mere 13 % of the 
placebo group displayed any progression of the disease during the 2-year 
follow-up time (Bingham et al. 2006). Obviously, no statistically 
significant difference between the placebo and the active treatment groups 
was found. Therefore, new and more powerful methods might produce 
substantial financial savings and improve the efficacy of clinical trials. 
However, at the moment, the only accepted end-point in clinical OA trials 
is the joint space narrowing (JSN) (Qvist et al. 2008). 
Furthermore, the development of novel pharmaceuticals will require 
that early OA changes can be reliably detected in order to allow targeting 
of these novel therapies. However, the earliest OA changes are often 
asymptomatic. For these reasons it is evident that the novel, more 
sensitive, quantitative methods for diagnosis of early OA changes in 
cartilage are urgently needed. Research on therapy and diagnosis of OA 
needs to progress in parallel in order to apply the results of these studies 
into clinical practice. 
Articular cartilage is a highly specialized connective tissue and its 
functional integrity can be generally determined by its mechanical 
properties. This necessitates an understanding of the structure-function 
relationship of the tissue. In study I, we were able to demonstrate that the 
lateral displacement of the cartilage tissue during compression, i.e. 
Poisson’s ratio, is primarily dependent upon the amount and 
organization of collagen. This clearly indicates that by investigating 
cartilage structure it is possible to evaluate its functionality. 
Several novel methods have been introduced for the determination of 
cartilage properties and as ways to detect early OA changes. These 
methods are typically intended to determine mechanical properties of the 
tissue, grade the degree of fibrillation or to determine the organization of 
collagen network or the PG content of the cartilage tissue. 
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Biomechanical properties of cartilage can be determined with several 
methods. Indentation of the cartilage surface can be conducted in vivo 
and also commercial applications have been developed for this purpose. 
Indentation testing of cartilage stiffness provides important information 
about cartilage status, since it gives direct information about cartilage 
functionality. Softening of cartilage is also known to take place during the 
degenerative process (Knecht et al. 2006). However, the use of stiffness 
values to distinguish early degeneration from healthy tissue can be 
challenging, as healthy cartilage demonstrates significant site-dependent 
variation. The results in study I highlighted the statistically significant 
variation in cartilage stiffness present at different joint surfaces. However, 
significant variation may exist also within one cartilage surface, as 
exemplified by the patellar cartilage surface in study III. Therefore in 
order to diagnose cartilage degeneration by measuring cartilage mechanical 
properties with high specificity, the obtained results should be compared 
location-wise with a precise map of the stiffness results of healthy 
cartilage. 
Indentation provides useful information about the cartilage, but the 
thickness of the tissue influences the results. In order to overcome this 
challenge, a novel ultrasound indentation method has been developed 
(Laasanen et al. 2002). With this method, it is possible to estimate 
cartilage thickness and deformation during the compression testing, and 
an estimate of the true mechanical modulus can be obtained. However, the 
use of the ultrasound method in estimating tissue thickness and 
deformation is subject to some errors in the thickness values, as the 
ultrasound speed has been observed to change during compression 
(Nieminen et al. 2007). Therefore, in order to minimize errors in stiffness 
values, methods to correct the ultrasound speed change during 
compression need to be developed. As these techniques are intended at 
diagnosing the earliest degenerative changes, it is important that the first 
signs of the decline in cartilage stiffness can be reliably detected. Despite 
these challenges, the indentation technique is capable of determining 
cartilage stiffness, as emphasized by the significant correlation coefficients 
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with the reference mechanical values. In the present study, the slight 
discrepancy between the actual measurements and reference values can be 
partially explained by the differences in measurement geometry, i.e. 
indentation vs. unconfined compression (Korhonen et al. 2002a). In this 
in situ study extensive care was targeted at precise and repeatable 
localization of the measurements due to site-dependent variation of 
cartilage mechanical properties. Therefore, this should not cause major 
variation between the results. However, the indentation setup was 
different between the techniques. Most likely the most significant reason 
for variation between the results is the detachment of cartilage plugs from 
the subchondral bone. This may enable significant swelling of the tissue 
and alter the mechanical properties of cartilage. 
Ultrasound has also been utilized to characterize cartilage structure. 
According to the present results, ultrasound signal reflection from 
cartilage surface is a sensitive parameter in distinguishing cartilage 
deterioration (studies II and III). RUS mainly reflects the integrity of the 
superficial cartilage layer. However, ultrasound reflection at the cartilage 
surface has been shown to relate closely to other degenerative processes 
within cartilage. Importantly, in study III, we were able to demonstrate 
that the RUS value exhibits no site-dependent variations in healthy 
cartilage, and that the results between healthy cartilage and those with 
early degeneration displayed statistically significant differences. Further, 
the ultrasound reflection measurements showed the highest sensitivity and 
specificity values when compared with other diagnostic methods (study 
II). These findings are of importance as they suggest that ultrasound 
measurements could be used to detect reliably the earliest degenerative 
changes in articular cartilage. 
The RUS measurements face the challenges encountered with any spot-
like measurements, whereas 2D ultrasound imaging can be used to map 
larger areas of cartilage surfaces. Ultrasound imaging can also be used to 
evaluate changes in the cartilage-subchondral bone interface (Saarakkala 
et al. 2006). However, the restricted penetration of the high-resolution 
ultrasound signal limits its potential to assess the intra-articular 
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structures transcutaneously. Therefore, in order to obtain images with the 
highest resolution, an intra-articular approach is necessary. The 
development of the intra-articular ultrasound technique might enable 
evaluation of intra-articular structures analogously to the way that 
vascular structures can be evaluated with intra-venous ultrasound 
catheters (Viren et al. 2009). This would require only a minimally invasive 
approach and these methods could be used to quantify cartilage status 
during arthroscopic procedures. Ultrasound imaging of joint structures 
can be performed non-invasively (Grassi et al. 2005), but evaluation of 
articular cartilage transcutaneously is challenging due to the limitations 
of acoustic window, whereby only limited visibility can be achieved of 
cartilaginous areas of most joints. Ultrasound speed seems to be a sensitive 
and specific measure of cartilage deterioration, but so far there are no 
reliable methods for determining ultrasound speed in vivo. 
Magnetic resonance imaging has long been used as an imaging 
modality for soft tissues. Typically, cartilage lesions are evaluated by 
visual assessment by a radiologist. With high-resolution MRI devices, it is 
possible to quantify cartilage volume, which has been shown to be weakly 
associated with OA symptoms (Wluka et al. 2004). However, in order to 
evaluate the early OA changes, volumetric evaluation is not sufficiently 
sensitive, and therefore quantitative MRI methods have been developed for 
diagnosing the changes associated with OA (Raynauld et al. 2004). In 
dGEMRIC, T1 relaxation of cartilage is determined in the presence of a 
negatively charged contrast agent (gadopentetate dimeglumine), which is 
considered to distribute in cartilage inversely to the tissue PG content as 
both compounds have a negative charge (Bashir et al. 1996). Therefore 
early loss of the PG molecules in cartilage would be revealed by an 
increased concentration of gadolinium and this can be indirectly detected 
through the altered T1 relaxation times. Determination of T2 relaxation 
times has been suggested to permit the assessment of the collagen network 
of cartilage (Goodwin et al. 1998, Nieminen et al. 2001, Xia et al. 2001). 
The preliminary studies with these methods showed significant 
correlations with the cartilage mechanical and compositional properties in 
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vitro. However, recent in situ research articles detected only a modest 
relationship of dGEMRIC and T2 with the mechanical parameters or 
composition and organization of the cartilage matrix (Lammentausta et al. 
2006, Lammentausta et al. 2007).  
The development of MRI methods has been very rapid and a rather 
limited discussion of the techniques has been conducted before the 
methods have been adapted to clinical trials as putative reference 
methods. In early dGEMRIC studies the concentration of the contrast 
agent was substantially higher than that which can be achieved in the 
clinical situations via intravenous dosing. In addition, recent studies on 
contrast agent diffusion times in cartilage indicate that the diffusion of 
the contrast agents is rather slow in native cartilage (Kallioniemi et al. 
2007, Silvast et al. 2009a, Silvast et al. 2009b). Therefore, the penetration 
of the contrast agent may not have achieved diffusion equilibrium when 
imaging is conducted 2 hours after the intravenous injection of the 
contrast agent. 
Furthermore, the early studies used enzymatic degradation of collagen 
or PGs of cartilage (Bashir et al. 1996), an extreme approach, which 
produced high correlation values. The specific enzymatic degradation of 
the main components of the tissue differs from the changes occurring 
during spontaneous OA, where both components alter concurrently. As 
MRI methods are non-invasive, they are attractive reference methods for 
clinical studies. However, caution is necessary and one must speculate 
whether the validation of these methods for clinical use has been 
inadequate, especially if they are being used as the basis for individual 
therapeutic decisions. Our results from study II also support this view, 
since the specificity and sensitivity values did not achieve the levels 
required for clinical techniques. 
As with any diagnostic technique, one should prefer non-invasive 
methods. However, today the knee arthroscopy procedure is often 
performed also in young individuals with symptomatic knee joints, and an 
extensive number of arthroscopic operations are performed annually. It 
would be optimal if quantitative data on cartilage status could be 
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obtained during routine arthroscopy. Monitoring these patients carefully 
and determining the characteristics that can best predict the progression 
to clinical OA at later age, may represent the best way to improve early 
diagnostics of OA and help in the prevention of the progression of the 
disease. The need for arthroscopies is not likely to decrease, and therefore 
also methods that are based on an arthroscopic approach should be 
developed in order to collect as much useful information as possible 
during the same operation. 
Most of the methods evaluated in this thesis work may have the 
potential for clinical measurements as they revealed acceptable specificity 
and sensitivity in discerning healthy cartilage from samples with signs of 
early or advanced degeneration. Furthermore, they showed good 
correlations with the reference parameters. It should be noted that some 
methods seem to be more strongly associated with specific reference 
parameters than others. When compared to each other, the individual 
diagnostic methods have different advantages and challenges  (Table 
9.1). Optimally, the selection of the method for use should be tailored 
individually, as some parameters seem to reflect biochemical properties, 
while others are more sensitive at detecting changes in the structure of the 
cartilage surface. Possibly, the biophysical diagnostic methods can also be 
divided into different categories similarly as has been suggested for 
biomarkers (Bauer et al. 2006). While some tests are suitable for early 
diagnostics of OA, others may be more suitable as prognostic tools or in 
measuring efficacy of medical interventions. An analogy to clinical MRI 
can be drawn – the most suited method should be selected based on the 
clinical phrasing of the question, just as in MRI studies, the most suitable 
pulse sequences are selected. In particular, in clinical pharmacological 
research, the selected end-point methods must be chosen so that they 
measure as accurately as possible the process that the particular drug is 
intended to alter.  
At the moment, the treatment of OA is far from optimal and better 
methods for diagnosing and treating this disease are needed. The 
development of this area of research is strictly linked to research into OA 
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therapeutics. At the point when the methodology is being selected for 
clinical diagnosis of early cartilage degeneration, it would be beneficial to 
have accurate, non-invasive and highly sensitive and preferably 
inexpensive screening methods. The positive results from this screening 
could be confirmed with further studies at higher specificities. 
Potentially these screening methods could be applied after 
multidimensional OA risk assessment. This risk assessment could use 
information about known risk factors for OA, such as gender, age, weight, 
type and time of joint injury, genetic factors and loading conditions. Then 
the screening tests could be targeted at those individuals at a high risk for 
OA. These kinds of risk assessment tests do not exist at the moment, but 
they might be worthy of study. If the sensitive screening method 
implicates the presence of cartilage degeneration, further studies could be 
performed to confirm the diagnosis and to help with the decision on how 
best to treat the patient. 
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Table 9.1 Advantages and challenges of the novel quantitative methods for 
sensitive diagnostics of OA 
 
The research on OA diagnostics and therapeutics is limited by the lack 
of knowledge about the etiopathogenesis of the entire OA process: it is not 
known which changes are signs of the progressive disease and which 
Method Sensitivity 
Specificity 
Advantages Challenges 
Plain 
radiographs 
- 
+++ 
 
• Non-invasive, easy to perform 
• Simultaneous bone diagnostics 
• Cheap 
• Good availability 
• No direct information 
on cartilage 
• Poor sensitivity 
• Radiation exposure 
Quantitative 
MRI 
++ 
++ 
• Non-invasive 
• No radiation exposure 
• Information on cartilage PGs 
(T1Gd) and collagen (T2) 
• Simultaneous diagnostics of other 
soft tissues 
• Expensive as 
compared with 
radiographs 
• Poor availability 
 
Indentation/ 
Ultrasound 
indentation 
+++ 
+++ 
• Can be performed during routine 
arthroscopic procedures 
• Direct information on cartilage 
function 
• Minimally invasive  
• In vivo measurement 
of certain locations can 
be challenging in US 
indentation 
Ultrasound 
speed and 
attenuation 
 
++ 
++ 
• Changes associate strongly with 
several determinants of cartilage 
integrity 
• Lack of clinically 
applicable 
measurement devices 
Ultrasound 
imaging of 
cartilage 
surface 
+++ 
+++ 
• Changes in cartilage surface seem 
to reflect alterations in cartilage 
quality as well as mechanical and 
compositional properties of 
cartilage 
• Initial degeneration alters these 
parameters 
• At the moment no 
arthroscopic 
instrumentation exists 
• Requires at least 
minimally invasive 
approach 
Streaming 
potentials 
? 
? 
• Indirect information about 
cartilage composition 
• Minimally invasive 
OCT ? 
? 
• Good spatial resolution 
• Method could be developed for 
arthroscopic use 
• Information only on 
superficial cartilage 
Biochemical 
biomarkers 
? 
- 
• Availability is good: Samples can 
be analyzed in a central 
laboratory 
• Affordable prizing 
• At the moment no 
methods exist for 
diagnosis at individual 
level 
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changes typically heal by themselves. Furthermore, a major proportion of 
advanced OA with radiographic changes is asymptomatic (Felson 1987). 
Therefore, extensive multidisciplinary follow-up studies are needed to 
elucidate this process. Even though no pharmaceutical solutions are 
currently available, it has been shown that by targeting specific OA risk 
factors, such as obesity, beneficial results can be obtained in OA 
treatment. Therefore, it would be interesting to test whether patients with 
an early OA diagnosis could be motivated to change their lifestyles and 
what is the effect on OA progression of this lifestyle modification. 
Obviously, the importance of early diagnostics of OA will be emphasized 
after effective medication for OA has been developed. 
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10  Conclusions 
In this study, quantitative diagnostic methods for early OA were used to 
determine properties of healthy and degenerated articular cartilage. The 
sensitivity and specificity of these methods was determined. Furthermore, 
the results of diagnostic tests were compared with histological, mechanical, 
compositional and acoustic reference parameters. In addition, the effect of 
cartilage composition on tissue Poisson’s ratio was studied. The main 
conclusions can be summarized as follows: 
 
1. The collagen content and organization were found to be the primary 
determinants of cartilage dynamic modulus and Poisson’s ratio. 
 
2. A comparison of novel methods for the diagnosis of early cartilage 
degeneration revealed that several methods are capable of sensitively 
and specifically diagnosing early cartilage degeneration. Some of these 
methods offer potential for development into clinical use, but the 
selection of the most suitable method should be made individually. 
 
3. Healthy human patellar cartilage displayed a statistically significant 
site-dependent variation in the compositional and mechanical 
properties of the tissue. The OA process was found to affect these 
properties in a non-uniform pattern. 
 
4. RUS was the only parameter, where no site-dependent variation was 
found in healthy patellae. Furthermore, it was the only diagnostic 
parameter for which there were statistically significant differences 
detected between healthy tissue and early OA changes. This parameter 
was also found to offer high specificity and sensitivity. With respect to 
the mechanical parameters, no statistically significant differences were 
found between the healthy samples and those with early degeneration. 
This was most likely due to the site-dependent variations in the 
mechanical properties of the patellar cartilage. 
 
5. A change in ultrasound speed during compression was observed. This 
was found to confer a significant error in the mechano-acoustically 
determined modulus values. To minimize its impact on cartilage 
mechanical moduli values, a correction method should be developed. 
Without correction, the change in ultrasound speed seems to be low in 
samples with advanced degeneration, and therefore results obtained 
from these kinds of samples were reliable. 
 83 
References 
[1] Adams SB, Jr., Herz PR, Stamper DL, Roberts MJ, Bourquin S, Patel 
NA, et al. High-resolution imaging of progressive articular cartilage 
degeneration. J Orthop Res. 2006;24:708-15. 
[2] Adis R&D Profile. Naproxcinod: AZD 3582, HCT 3012, naproxen 
nitroxybutylester, nitronaproxen, NO-naproxen. Drugs R D. 2007;8:255-8. 
[3] Adler RS, Dedrick DK, Laing TJ, Chiang EH, Meyer CR, Bland PH, et 
al. Quantitative assessment of cartilage surface roughness in osteoarthritis 
using high frequency ultrasound. Ultrasound Med Biol. 1992;18:51-8. 
[4] Ahmed AM and Burke DL. In-vitro measurement of static pressure 
distribution in synovial joints- -Part I: Tibial surface of the knee. J 
Biomech Eng. 1983;105:216-25. 
[5] Aigner T, Hemmel M, Neureiter D, Gebhard PM, Zeiler G, Kirchner T, 
et al. Apoptotic cell death is not a widespread phenomenon in normal 
aging and osteoarthritis human articular knee cartilage: a study of 
proliferation, programmed cell death (apoptosis), and viability of 
chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis 
Rheum. 2001;44:1304-12. 
[6] Aigner T and Dudhia J. Genomics of osteoarthritis. Curr Opin 
Rheumatol. 2003;15:634-40. 
[7] Aigner T, Sachse A, Gebhard PM and Roach HI. Osteoarthritis: 
pathobiology-targets and ways for therapeutic intervention. Adv Drug 
Deliv Rev. 2006;58:128-49. 
[8] Aisen AM, McCune WJ, MacGuire A, Carson PL, Silver TM, Jafri SZ, 
et al. Sonographic evaluation of the cartilage of the knee. Radiology. 
1984;153:781-4. 
[9] Akella SV, Regatte RR, Gougoutas AJ, Borthakur A, Shapiro EM, 
Kneeland JB, et al. Proteoglycan-induced changes in T1rho-relaxation of 
articular cartilage at 4T. Magn Reson Med. 2001;46:419-23. 
[10] Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. 
Development of criteria for the classification and reporting of 
osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and 
Therapeutic Criteria Committee of the American Rheumatism Association. 
Arthritis Rheum. 1986;29:1039-49. 
[11] Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt 
K, et al. The American College of Rheumatology criteria for the 
 84 
classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 
1990;33:1601-10. 
[12] Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt 
K, et al. The American College of Rheumatology criteria for the 
classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 
1991;34:505-14. 
[13] Altman RD, Hochberg MC, Moskowitz RW and Schnitzer TJ. 
Recommendations for the medical management of osteoarthritis of the hip 
and knee: 2000 update. American College of Rheumatology Subcommittee 
on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905-15. 
[14] Altman RD. Structure-/disease-modifying agents for osteoarthritis. 
Semin Arthritis Rheum. 2005;34:3-5. 
[15] Appleyard RC, Swain MV, Khanna S and Murrel GAC. The accuracy 
and reliability of a novel handheld dynamic indentation probe for 
analysing articular cartilage. Physics in medicine and biology. 
2001;46:541-550. 
[16] Arden N and Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res 
Clin Rheumatol. 2006;20:3-25. 
[17] Arokoski JP, Hyttinen MM, Lapveteläinen T, Takacs P, Kosztaczky B, 
Modis L, et al. Decreased birefringence of the superficial zone collagen 
network in the canine knee (stifle) articular cartilage after long distance 
running training, detected by quantitative polarised light microscopy. 
Ann Rheum Dis. 1996;55:253-64. 
[18] Arokoski JPA, Manninen P, Kröger H, Heliövaara M, Nykyri E and 
Impivaara O. Hip and Knee Pain and Osteoarthritis. In editors. 
Musculoskeletal Disorders and Diseases in Finland, pages 37-41. Helsinki: 
National Public Health Institute, Finland; 2007. 
[19] Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res 
Clin Rheumatol. 2001;15:609-26. 
[20] Bader DL, Kempson GE, Barrett AJ and Webb W. The effects of 
leucocyte elastase on the mechanical properties of adult human articular 
cartilage in tension. Biochim Biophys Acta. 1981;677:103-8. 
[21] Bader DL, Kempson GE, Egan J, Gilbey W and Barrett AJ. The 
effects of selective matrix degradation on the short-term compressive 
properties of adult human articular cartilage. Biochim Biophys Acta. 
1992;1116:147-54. 
[22] Bader DL and Kempson GE. The short-term compressive properties of 
adult human articular cartilage. Biomed Mater Eng. 1994;4:245-56. 
 85 
[23] Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, 
Mindeholm L, et al. Oral salmon calcitonin induced suppression of 
urinary collagen type II degradation in postmenopausal women: a new 
potential treatment of osteoarthritis. Bone. 2005;37:425-30. 
[24] Bank RA, Bayliss MT, Lafeber FP, Maroudas A and Tekoppele JM. 
Ageing and zonal variation in post-translational modification of collagen 
in normal human articular cartilage. The age-related increase in non-
enzymatic glycation affects biomechanical properties of cartilage. Biochem 
J. 1998;330:345-51. 
[25] Bannwarth B. Acetaminophen or NSAIDs for the treatment of 
osteoarthritis. Best Pract Res Clin Rheumatol. 2006;20:117-29. 
[26] Bashir A, Gray ML and Burstein D. Gd-DTPA2- as a measure of 
cartilage degradation. Magn Reson Med. 1996;36:665-73. 
[27] Bashir A, Gray ML, Hartke J and Burstein D. Nondestructive 
imaging of human cartilage glycosaminoglycan concentration by MRI. 
Magn Reson Med. 1999;41:857-65. 
[28] Bateman JF. Genetic aspects of osteoarthritis. Semin Arthritis 
Rheum. 2005;34:15-8. 
[29] Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, et 
al. Classification of osteoarthritis biomarkers: a proposed approach. 
Osteoarthritis Cartilage. 2006;14:723-7. 
[30] Bennell K and Hinman R. Exercise as a treatment for osteoarthritis. 
Curr Opin Rheumatol. 2005;17:634-40. 
[31] Benninghoff A. Form und bau der gelenkknorpel in ihren 
beziehungen zur function. Erste mitteilung: Die modellierenden und 
formerhaltenden faktoren des knorpelreliefs. Z Gesampte Abt. 1925;76:43-
63. 
[32] Bingham CO, Buckland-Wright JC, Garnero P, Cohen SB, Dougados 
M, Adami S, et al. Risedronate decreases biochemical markers of cartilage 
degradation but does not decrease symptoms or slow radiographic 
progression in patients with medial compartment osteoarthritis of the 
knee: results of the two-year multinational knee osteoarthritis structural 
arthritis study. Arthritis Rheum. 2006;54:3494-507. 
[33] Blalock HM. Social Statistics. New York: McGraw-Hill; 1972. 
[34] Blumenkrantz G and Majumdar S. Quantitative magnetic resonance 
imaging of articular cartilage in osteoarthritis. Eur Cell Mater. 2007;13:76-
86. 
[35] Blumenkrantz N and Asboe-Hansen G. New method for quantitative 
determination of uronic acids. Anal Biochem. 1973;54:484-9. 
 86 
[36] Braddock M and Quinn A. Targeting IL-1 in inflammatory disease: 
new opportunities for therapeutic intervention. Nat Rev Drug Discov. 
2004;3:330-9. 
[37] Bradley JD, Heilman DK, Katz BP, Gsell P, Wallick JE and Brandt 
KD. Tidal irrigation as treatment for knee osteoarthritis: a sham-
controlled, randomized, double-blinded evaluation. Arthritis Rheum. 
2002;46:100-8. 
[38] Brama PA, Tekoppele JM, Bank RA, Barneveld A, Firth EC and van 
Weeren PR. The influence of strenuous exercise on collagen characteristics 
of articular cartilage in Thoroughbreds age 2 years. Equine Vet J. 
2000;32:551-4. 
[39] Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum 
DE, et al. Effects of doxycycline on progression of osteoarthritis: results of 
a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 
2005;52:2015-25. 
[40] Brandt KD, Radin EL, Dieppe PA and van de Putte L. Yet more 
evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis. 
2006;65:1261-4. 
[41] Brittberg M and Winalski CS. Evaluation of cartilage injuries and 
repair. J Bone Joint Surg Am. 2003;85-A:58-69. 
[42] Brooks PM. Impact of osteoarthritis on individuals and society: how 
much disability? Social consequences and health economic implications. 
Curr Opin Rheumatol. 2002;14:573-7. 
[43] Brouwer RW, Jakma TS, Bierma-Zeinstra SM, Verhagen AP and 
Verhaar J. Osteotomy for treating knee osteoarthritis. Cochrane Database 
Syst Rev. 2005;CD004019. 
[44] Brown H and Prescott R. Applied Mixed Models in Medicine. 
Hoboken, New Jersey: Wiley; 2006. 
[45] Buckwalter JA. Osteoarthritis and articular cartilage use, disuse, and 
abuse: experimental studies. J Rheumatol  Suppl 43. 1995;22:1:13-15. 
[46] Buckwalter JA and Mankin HJ. Articular Cartilage, Part II: 
Degeneration and osteoarthritis, repair, regeneration, and 
transplantation. J Bone Joint Surg Am. 1997;79:612-32. 
[47] Buckwalter JA and Mankin HJ. Articular cartilage: degeneration and 
osteoarthritis, repair, regeneration, and transplantation. Instructional 
Course Lectures. 1998;47:487-504. 
[48] Buckwalter JA and Lappin DR. The disproportionate impact of 
chronic arthralgia and arthritis among women. Clin Orthop Relat Res. 
2000;159-68. 
 87 
[49] Buckwalter JA. Articular cartilage injuries. Clin Orthop Relat Res. 
2002;21-37. 
[50] Buckwalter JA, Saltzman C and Brown T. The impact of 
osteoarthritis: implications for research. Clin Orthop Relat Res. 2004;S6-
15. 
[51] Buckwalter JA and Martin JA. Osteoarthritis. Adv Drug Deliv Rev. 
2006;58:150-67. 
[52] Burrage PS and Brinckerhoff CE. Molecular targets in osteoarthritis: 
metalloproteinases and their inhibitors. Curr Drug Targets. 2007;8:293-
303. 
[53] Burstein D and Gray M. New MRI techniques for imaging cartilage. J 
Bone Joint Surg Am. 2003;85-A:70-7. 
[54] Camacho NP, West P, Torzilli PA and Mendelsohn R. FTIR 
microscopic imaging of collagen and proteoglycan in bovine cartilage. 
Biopolymers. 2001;62:1-8. 
[55] Carney SL and Muir H. The structure and function of cartilage 
proteoglycans. Physiol Rev. 1988;68:858-910. 
[56] Carr AJ. Beyond disability: measuring the social and personal 
consequences of osteoarthritis. Osteoarthritis Cartilage. 1999;7:230-8. 
[57] Cawston TE and Wilson AJ. Understanding the role of tissue 
degrading enzymes and their inhibitors in development and disease. Best 
Pract Res Clin Rheumatol. 2006;20:983-1002. 
[58] Chang RW, Pellisier JM and Hazen GB. A cost-effectiveness analysis 
of total hip arthroplasty for osteoarthritis of the hip. JAMA. 
1996;275:858-65. 
[59] Cherin E, Saied A, Laugier P, Netter P and Berger G. Evaluation of 
acoustical parameter sensitivity to age-related and osteoarthritic changes 
in articular cartilage using 50-MHz ultrasound. Ultrasound Med Biol. 
1998;24:341-54. 
[60] Chérin E, Saïed A, Laugier P, Netter P and Berger G. Evaluation of 
acoustical parameter sensitivity to age-related and osteoarthritic changes 
in articular cartilage using 50-MHz ultrasound. Ultrasound Med Biol. 
1998;24:341-54. 
[61] Chiang EH, Adler RS, Meyer CR, Rubin JM, Dedrick DK and Laing 
TJ. Quantitative assessment of surface roughness using backscattered 
ultrasound: the effects of finite surface curvature. Ultrasound Med Biol. 
1994;20:123-35. 
[62] Chiang EH, Laing TJ, Meyer CR, Boes JL, Rubin JM and Adler RS. 
Ultrasonic characterization of in vitro osteoarthritic articular cartilage 
 88 
with validation by confocal microscopy. Ultrasound Med Biol. 1997;23:205-
13. 
[63] Christgau S and Cloos PAC. Cartilage degradation products as 
markers for evaluation of patients with rheumatic disease. Clin Appl 
Immun Rev. 2004;4:277-94. 
[64] Cibere J. Do we need radiographs to diagnose osteoarthritis? Best 
Pract Res Clin Rheumatol. 2006;20:27-38. 
[65] Cicuttini FM and Spector TD. Genetics of osteoarthritis. Ann Rheum 
Dis. 1996;55:665-7. 
[66] Cimmino MA and Parodi M. Risk factors for osteoarthritis. Semin 
Arthritis Rheum. 2005;34:29-34. 
[67] Cimmino MA and Grassi W. What is new in ultrasound and 
magnetic resonance imaging for musculoskeletal disorders? Best Pract Res 
Clin Rheumatol. 2008;22:1141-8. 
[68] Claessens AA, Schouten JS, van den Ouweland FA and Valkenburg 
HA. Do clinical findings associate with radiographic osteoarthritis of the 
knee? Ann Rheum Dis. 1990;49:771-4. 
[69] Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et 
al. Glucosamine, chondroitin sulfate, and the two in combination for 
painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. 
[70] Collett E. Polarized light: Fundamentals and Applications. New York: 
Marcel Dekker, Inc.; 1992. 
[71] Conaghan P, D'Agostino MA, Ravaud P, Baron G, Le Bars M, Grassi 
W, et al. EULAR report on the use of ultrasonography in painful knee 
osteoarthritis. Part 2: exploring decision rules for clinical utility. Ann 
Rheum Dis. 2005;64:1710-4. 
[72] Conaghan P. Is MRI useful in osteoarthritis? Best Pract Res Clin 
Rheumatol. 2006;20:57-68. 
[73] Conaghan P, Birrel F, Burke M, Cumming J, Dickson J, Dieppe P, et 
al. Osteoarthritis: National clinical guideline for care and management in 
adults. London: NICE, Royal College of Physicians; 2008. 
[74] Corti MC and Rigon C. Epidemiology of osteoarthritis: prevalence, 
risk factors and functional impact. Aging Clin Exp Res. 2003;15:359-63. 
[75] Corvol MT. The chondrocyte: from cell aging to osteoarthritis. Joint 
Bone Spine. 2000;67:557-60. 
[76] Crepaldi G and Punzi L. Aging and osteoarthritis. Aging Clin Exp 
Res. 2003;15:355-8. 
 89 
[77] D'Agostino MA, Conaghan P, Le Bars M, Baron G, Grassi W, 
Martin-Mola E, et al. EULAR report on the use of ultrasonography in 
painful knee osteoarthritis. Part 1: prevalence of inflammation in 
osteoarthritis. Ann Rheum Dis. 2005;64:1703-9. 
[78] Davies-Tuck ML, Wluka AE, Wang Y, Teichtahl AJ, Jones G, Ding 
C, et al. The natural history of cartilage defects in people with knee 
osteoarthritis. Osteoarthritis Cartilage. 2008;16:337-42. 
[79] Davis CR, Karl J, Granell R, Kirwan JR, Fasham J, Johansen J, et 
al. Can biochemical markers serve as surrogates for imaging in knee 
osteoarthritis? Arthritis Rheum. 2007;56:4038-47. 
[80] Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS and Woessner 
JF, Jr. Evidence for metalloproteinase and metalloproteinase inhibitor 
imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678-85. 
[81] Dervin GF, Stiell IG, Rody K and Grabowski J. Effect of arthroscopic 
debridement for osteoarthritis of the knee on health-related quality of life. 
J Bone Joint Surg Am. 2003;85-A:10-9. 
[82] Dieppe PA and Lohmander LS. Pathogenesis and management of 
pain in osteoarthritis. Lancet. 2005;365:965-73. 
[83] Dillon CF, Rasch EK, Gu Q and Hirsch R. Prevalence of knee 
osteoarthritis in the United States: arthritis data from the Third National 
Health and Nutrition Examination Survey 1991-94. J Rheumatol. 
2006;33:2271-9. 
[84] Disler DG, Raymond E, May DA, Wayne JS and McCauley TR. 
Articular cartilage defects: in vitro evaluation of accuracy and 
interobserver reliability for detection and grading with US. Radiology. 
2000;215:846-51. 
[85] Dixon T, Shaw M, Ebrahim S and Dieppe P. Trends in hip and knee 
joint replacement: socioeconomic inequalities and projections of need. Ann 
Rheum Dis. 2004;63:825-30. 
[86] Dodge GR and Poole AR. Immunohistochemical detection and 
immunochemical analysis of type II collagen degradation in human 
normal, rheumatoid, and osteoarthritic articular cartilages and in 
explants of bovine articular cartilage cultured with interleukin 1. J Clin 
Invest. 1989;83:647-61. 
[87] Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E and 
Lequesne M. Evaluation of the structure-modifying effects of diacerein in 
hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. 
Evaluation of the Chondromodulating Effect of Diacerein in OA of the 
Hip. Arthritis Rheum. 2001;44:2539-47. 
 90 
[88] Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans 
DJ, et al. The surface of articular cartilage contains a progenitor cell 
population. J Cell Sci. 2004;117:889-97. 
[89] Duda GN, Kleemann RU, Bluecher U and Weiler A. A new device to 
detect early cartilage degeneration. Am J Sports Med. 2004;32:693-8. 
[90] Dunn TC, Lu Y, Jin H, Ries MD and Majumdar S. T2 relaxation 
time of cartilage at MR imaging: comparison with severity of knee 
osteoarthritis. Radiology. 2004;232:592-8. 
[91] Eckstein F, Sittek H, Milz S, Putz R and Reiser M. The morphology 
of articular cartilage assessed by magnetic resonance imaging (MRI). 
Reproducibility and anatomical correlation. Surg Radiol Anat. 
1994;16:429-38. 
[92] Eckstein F, Charles HC, Buck RJ, Kraus VB, Remmers AE, 
Hudelmaier M, et al. Accuracy and precision of quantitative assessment of 
cartilage morphology by magnetic resonance imaging at 3.0T. Arthritis 
Rheum. 2005;52:3132-6. 
[93] Ettinger WH, Jr., Burns R, Messier SP, Applegate W, Rejeski WJ, 
Morgan T, et al. A randomized trial comparing aerobic exercise and 
resistance exercise with a health education program in older adults with 
knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). 
JAMA. 1997;277:25-31. 
[94] Evans CH, Gouze JN, Gouze E, Robbins PD and Ghivizzani SC. 
Osteoarthritis gene therapy. Gene Ther. 2004;11:379-89. 
[95] Evans CH, Gouze E, Gouze JN, Robbins PD and Ghivizzani SC. 
Gene therapeutic approaches-transfer in vivo. Adv Drug Deliv Rev. 
2006;58:243-58. 
[96] Eyre DR. Collagen of articular cartilage. Arthritis Res. 2002;4:30-5. 
[97] Eyre DR. Collagens and cartilage matrix homeostasis. Clin Orthop 
Relat Res. 2004;S118-22. 
[98] Eyre DR, Weis MA and Wu JJ. Articular cartilage collagen: an 
irreplaceable framework? Eur Cell Mater. 2006;12:57-63. 
[99] Fam H, Bryant JT and Kontopoulou M. Rheological properties of 
synovial fluids. Biorheology. 2007;44:59-74. 
[100] Felson DT, Naimark A, Anderson J, Kazis L, Castelli W and Meenan 
RF. The prevalence of knee osteoarthritis in the elderly. The Framingham 
Osteoarthritis Study. Arthritis Rheum. 1987;30:914-8. 
[101] Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol 
Rev. 1988;10:1-28. 
 91 
[102] Felson DT, Anderson JJ, Naimark A, Walker AM and Meenan RF. 
Obesity and knee osteoarthritis. The Framingham Study. Ann Intern 
Med. 1988;109:18-24. 
[103] Felson DT, Zhang Y, Anthony JM, Naimark A and Anderson JJ. 
Weight loss reduces the risk for symptomatic knee osteoarthritis in women. 
The Framingham Study. Ann Intern Med. 1992;116:535-9. 
[104] Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, 
Aliabadi P, et al. The incidence and natural history of knee osteoarthritis 
in the elderly. Arthritis & Rheumatism. 1995;38:1500-1505. 
[105] Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, 
Aliabadi P, et al. Risk factors for incident radiographic knee osteoarthritis 
in the elderly: the Framingham Study. Arthritis Rheum. 1997;40:728-33. 
[106] Felson DT and Zhang Y. An update on the epidemiology of knee 
and hip osteoarthritis with a view to prevention. Arthritis Rheum. 
1998;41:1343-55. 
[107] Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan 
JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk 
factors. Ann Intern Med. 2000;133:635-46. 
[108] Felson DT. Risk factors for osteoarthritis: understanding joint 
vulnerability. Clin Orthop Relat Res. 2004;S16-21. 
[109] Felson DT, Goggins J, Niu J, Zhang Y and Hunter DJ. The effect of 
body weight on progression of knee osteoarthritis is dependent on 
alignment. Arthritis Rheum. 2004a;50:3904-9. 
[110] Felson DT and Neogi T. Osteoarthritis: is it a disease of cartilage or 
of bone? Arthritis Rheum. 2004b;50:341-4. 
[111] Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J 
Med. 2006;354:841-8. 
[112] Filidoro L, Dietrich O, Weber J, Rauch E, Oerther T, Wick M, et al. 
High-resolution diffusion tensor imaging of human patellar cartilage: 
feasibility and preliminary findings. Magn Reson Med. 2005;53:993-8. 
[113] Fioravanti A, Cantarini L, Fabbroni M, Righeschi K and 
Marcolongo R. Methods used to assess clinical outcome and quality of life 
in osteoarthritis. Semin Arthritis Rheum. 2005;34:70-2. 
[114] Forster H and Fisher J. The influence of loading time and lubricant 
on the friction of articular cartilage. Proc Inst Mech Eng [H]. 
1996;210:109-19. 
[115] Forster H and Fisher J. The influence of continuous sliding and 
subsequent surface wear on the friction of articular cartilage. Proc Inst 
Mech Eng [H]. 1999;213:329-45. 
 92 
[116] Franceschini R, Franceschini M, Romano P, Bussi P, Caruso EM 
and De Amici S. Joint replacement in osteoarthritis: state of the art. 
Semin Arthritis Rheum. 2005;34:73-7. 
[117] Fransen M and McConnell S. Exercise for osteoarthritis of the knee. 
Cochrane Database Syst Rev. 2008;CD004376. 
[118] Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH and McIlwraith 
CW. Treatment of experimental equine osteoarthritis by in vivo delivery of 
the equine interleukin-1 receptor antagonist gene. Gene Ther. 2002;9:12-
20. 
[119] Frizziero L, Reta M, Rizzuti F, Zizzi F, Frizziero A and Facchini A. 
Surgical approaches in osteoarthritis: role of arthroscopy. Semin Arthritis 
Rheum. 2005;34:53-7. 
[120] Garnero P, Rousseau JC and Delmas PD. Molecular basis and 
clinical use of biochemical markers of bone, cartilage, and synovium in 
joint diseases. Arthritis Rheum. 2000;43:953-68. 
[121] Garon M, Légaré A, Guardo R, Savard P and Buschmann MD. 
Streaming potentials maps are spatially resolved indicators of amplitude, 
frequency and ionic strength dependant responses of articular cartilage to 
load. J Biomech. 2002;35:207-16. 
[122] Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM and 
Klag MJ. Joint injury in young adults and risk for subsequent knee and 
hip osteoarthritis. Ann Intern Med. 2000;133:321-8. 
[123] Gerwin N, Hops C and Lucke A. Intraarticular drug delivery in 
osteoarthritis. Adv Drug Deliv Rev. 2006;58:226-42. 
[124] Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis 
Rheum. 2000;43:1916-26. 
[125] Goldring MB and Berenbaum F. The regulation of chondrocyte 
function by proinflammatory mediators: prostaglandins and nitric oxide. 
Clin Orthop Relat Res. 2004;S37-46. 
[126] Goldring MB. Update on the biology of the chondrocyte and new 
approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol. 
2006;20:1003-25. 
[127] Goodwin DW, Wadghiri YZ and Dunn JF. Micro-imaging of 
articular cartilage: T2, proton density, and the magic angle effect. Acad 
Radiol. 1998;5:790-8. 
[128] Gossec L and Dougados M. Do intra-articular therapies work and 
who will benefit most? Best Pract Res Clin Rheumatol. 2006;20:131-44. 
[129] Grassi W, Filippucci E and Farina A. Ultrasonography in 
osteoarthritis. Semin Arthritis Rheum. 2005;34:19-23. 
 93 
[130] Gray ML, Burstein D, Lesperance LM and Lee G. Magnetization 
transfer in cartilage and its constituent macromolecules. Magnetic 
Resonance in Medicine. 1995;34:319-25. 
[131] Gray ML, Burstein D and Xia Y. Biochemical (and functional) 
imaging of articular cartilage. Semin Musculoskelet Radiol. 2001;5:329-43. 
[132] Gray ML, Eckstein F, Peterfy C, Dahlberg L, Kim YJ and Sorensen 
AG. Toward imaging biomarkers for osteoarthritis. Clin Orthop Relat Res. 
2004;S175-81. 
[133] Gunther KP and Sun Y. Reliability of radiographic assessment in 
hip and knee osteoarthritis. Osteoarthritis Cartilage. 1999;7:239-46. 
[134] Hannan MT, Felson DT and Pincus T. Analysis of the discordance 
between radiographic changes and knee pain in osteoarthritis of the knee. 
J Rheumatol. 2000;27:1513-7. 
[135] Hardingham TE and Muir H. Hyaluronic acid in cartilage and 
proteoglycan aggregation. Biochem J. 1974;139:565-81. 
[136] Hardingham TE and Fosang AJ. Proteoglycans: many forms and 
many functions. Faseb J. 1992;6:861-70. 
[137] Hart DJ and Spector TD. The classification and assessment of 
osteoarthritis. Baillieres Clin Rheumatol. 1995;9:407-32. 
[138] Hayes CW, Jamadar DA, Welch GW, Jannausch ML, Lachance LL, 
Capul DC, et al. Osteoarthritis of the knee: comparison of MR imaging 
findings with radiographic severity measurements and pain in middle-
aged women. Radiology. 2005;237:998-1007. 
[139] Hayes WC, Keer LM, Herrmann G and Mockros LF. A mathematical 
analysis for indentation tests of articular cartilage. J Biomech. 1972;5:541-
51. 
[140] Heliövaara M, Impivaara O, Nykyri E and Riihimäki H. Changes in 
morbidity. In editors. Musculoskeletal Disorders and Diseases in Finland, 
pages 60-69. Helsinki: National Public Health Institute, Finland; 2007. 
[141] Helminen HJ, Hyttinen MM, Lammi MJ, Arokoski JP, Lapveteläinen 
T, Jurvelin J, et al. Regular joint loading in youth assists in the 
establishment and strengthening of the collagen network of articular 
cartilage and contributes to the prevention of osteoarthrosis later in life: a 
hypothesis [In Process Citation]. J Bone Miner Metab. 2000;18:245-57. 
[142] Herrmann JM, Pitris C, Bouma BE, Boppart SA, Jesser CA, 
Stamper DL, et al. High resolution imaging of normal and osteoarthritic 
cartilage with optical coherence tomography. J Rheumatol. 1999;26:627-35. 
 94 
[143] Hochberg MC, Lethbridge-Cejku M, Scott WW, Jr., Plato CC and 
Tobin JD. Obesity and osteoarthritis of the hands in women. 
Osteoarthritis Cartilage. 1993;1:129-35. 
[144] Huber M, Trattnig S and Lintner F. Anatomy, biochemistry, and 
physiology of articular cartilage. Invest Radiol. 2000;35:573-80. 
[145] Hunter DJ and Felson DT. Osteoarthritis. Bmj. 2006;332:639-42. 
[146] Hunziker EB, Quinn TM and Hauselmann HJ. Quantitative 
structural organization of normal adult human articular cartilage. 
Osteoarthritis Cartilage. 2002;10:564-72. 
[147] Insko EK, Kaufman JH, Leigh JS and Reddy R. Sodium NMR 
evaluation of articular cartilage degradation. Magn Reson Med. 
1999;41:30-4. 
[148] Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, 
Woodard J, et al. Prevalence of knee symptoms and radiographic and 
symptomatic knee osteoarthritis in African Americans and Caucasians: the 
Johnston County Osteoarthritis Project. J Rheumatol. 2007;34:172-80. 
[149] Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, 
Dieppe P, et al. EULAR Recommendations 2003: an evidence based 
approach to the management of knee osteoarthritis: Report of a Task 
Force of the Standing Committee for International Clinical Studies 
Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-
55. 
[150] Julkunen P, Wilson W, Jurvelin JS, Rieppo J, Qu CJ, Lammi MJ, et 
al. Stress-relaxation of human patellar articular cartilage in unconfined 
compression: prediction of mechanical response by tissue composition and 
structure. J Biomech. 2008;41:1978-86. 
[151] Kaila-Kangas L. Musculoskeletal disorders and diseases in Finland. 
Helsinki: National Public Health Institute, Finland; 2007. 
[152] Kallioniemi AS, Jurvelin JS, Nieminen MT, Lammi MJ and Toyras 
J. Contrast agent enhanced pQCT of articular cartilage. Phys Med Biol. 
2007;52:1209-19. 
[153] Karsdal MA, Sondergaard BC, Arnold M and Christiansen C. 
Calcitonin affects both bone and cartilage: a dual action treatment for 
osteoarthritis? Ann N Y Acad Sci. 2007;1117:181-95. 
[154] Karsdal MA, Leeming DJ, Dam EB, Henriksen K, Alexandersen P, 
Pastoureau P, et al. Should subchondral bone turnover be targeted when 
treating osteoarthritis? Osteoarthritis Cartilage. 2008;16:638-46. 
[155] Katz JN. Total joint replacement in osteoarthritis. Best Pract Res 
Clin Rheumatol. 2006;20:145-53. 
 95 
[156] Kellgren JH and Lawrence JS. Radiological assessment of osteo-
arthrosis. Ann Rheum Dis. 1957;16:494-502. 
[157] Kellgren JH. Osteoarthrosis in patients and populations. Br Med J. 
1961;1-6. 
[158] Kellgren JH, Lawrence JS and Bier F. Genetic Factors in Generalized 
Osteo-Arthrosis. Ann Rheum Dis. 1963;22:237-55. 
[159] Kempson GE, Muir H, Swanson SAV and Freeman MAR. 
Correlations between stiffness and the chemical constituents of cartilage 
on the human femoral head. Biochim Biophys Acta. 1970;215:70-77. 
[160] Király K, Lapveteläinen T, Arokoski J, Törrönen K, Modis L, 
Kiviranta I, et al. Application of selected cationic dyes for the 
semiquantitative estimation of glycosaminoglycans in histological sections 
of articular cartilage by microspectrophotometry. Histochem J. 
1996;28:577-90. 
[161] Kirkwood TB. What is the relationship between osteoarthritis and 
ageing? Baillieres Clin Rheumatol. 1997;11:683-94. 
[162] Kiviranta I, Jurvelin J, Tammi M, Säämänen AM and Helminen HJ. 
Weight bearing controls glycosaminoglycan concentration and articular 
cartilage thickness in the knee joints of young beagle dogs. Arthritis 
Rheum. 1987;30:801-9. 
[163] Knecht S, Vanwanseele B and Stussi E. A review on the mechanical 
quality of articular cartilage - implications for the diagnosis of 
osteoarthritis. Clin Biomech (Bristol, Avon). 2006;21:999-1012. 
[164] Korhonen RK, Laasanen MS, Töyräs J, Helminen HJ and Jurvelin 
JS. Comparison of the equilibrium response of articular cartilage in 
unconfined compression, confined compression and indentation. J 
Biomech. 2002a;35:903-9. 
[165] Korhonen RK, Wong M, Arokoski J, Lindgren R, Helminen HJ, 
Hunziker EB, et al. Importance of the superficial tissue layer for the 
indentation stiffness of articular cartilage. Med Eng Phys. 2002b;24:99-
108. 
[166] Koyama E, Shibukawa Y, Nagayama M, Sugito H, Young B, Yuasa 
T, et al. A distinct cohort of progenitor cells participates in synovial joint 
and articular cartilage formation during mouse limb skeletogenesis. Dev 
Biol. 2008;316:62-73. 
[167] Krasnokutsky S, Samuels J and Abramson SB. Osteoarthritis in 
2007. Bull NYU Hosp Jt Dis. 2007;65:222-8. 
[168] Kraus VB. Do biochemical markers have a role in osteoarthritis 
diagnosis and treatment? Best Pract Res Clin Rheumatol. 2006;20:69-80. 
 96 
[169] Kurz B, Lemke AK, Fay J, Pufe T, Grodzinsky AJ and Schunke M. 
Pathomechanisms of cartilage destruction by mechanical injury. Ann 
Anat. 2005;187:473-85. 
[170] Laasanen MS, Töyräs J, Hirvonen J, Saarakkala S, Korhonen RK, 
Nieminen MT, et al. Novel mechano-acoustic technique and instrument for 
diagnosis of cartilage degeneration. Physiol Meas. 2002;23:491-503. 
[171] Laasanen MS, Töyräs J, Vasara AI, Hyttinen MM, Saarakkala S, 
Hirvonen J, et al. Mechano-acoustic diagnosis of cartilage degeneration 
and repair. J Bone Joint Surg Am. 2003;85-A Suppl 2:78-84. 
[172] Laasanen MS, Toyras J, Vasara A, Saarakkala S, Hyttinen MM, 
Kiviranta I, et al. Quantitative ultrasound imaging of spontaneous repair 
of porcine cartilage. Osteoarthritis Cartilage. 2006;14:258-63. 
[173] Lammentausta E, Kiviranta P, Nissi MJ, Laasanen MS, Kiviranta I, 
Nieminen MT, et al. T2 relaxation time and delayed gadolinium-enhanced 
MRI of cartilage (dGEMRIC) of human patellar cartilage at 1.5 T and 9.4 
T: Relationships with tissue mechanical properties. J Orthop Res. 
2006;24:366-74. 
[174] Lammentausta E, Kiviranta P, Toyras J, Hyttinen MM, Kiviranta I, 
Nieminen MT, et al. Quantitative MRI of parallel changes of articular 
cartilage and underlying trabecular bone in degeneration. Osteoarthritis 
Cartilage. 2007;15:1149-57. 
[175] Lane NE and Buckwalter JA. Exercise and osteoarthritis. Curr Opin 
Rheumatol. 1999;11:413-6. 
[176] Lane NE. Clinical practice. Osteoarthritis of the hip. N Engl J Med. 
2007;357:1413-21. 
[177] Lawrence JS, Bremner JM and Bier F. Osteo-arthrosis. Prevalence in 
the population and relationship between symptoms and x-ray changes. 
Ann Rheum Dis. 1966;25:1-24. 
[178] Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo 
RA, et al. Estimates of the prevalence of arthritis and other rheumatic 
conditions in the United States. Part II. Arthritis Rheum. 2008;58:26-35. 
[179] Legare A, Garon M, Quardo R, Savard P, Poole AR and Buschmann 
MD. Detection and analysis of cartilage degeneration by spatially resolved 
streaming potentials. J Orthop Res. 2002;20:819-826. 
[180] Lohmander LS, Atley LM, Pietka TA and Eyre DR. The release of 
crosslinked peptides from type II collagen into human synovial fluid is 
increased soon after joint injury and in osteoarthritis. Arthritis Rheum. 
2003;48:3130-9. 
 97 
[181] Lu MH, Zheng YP and Huang QH. A novel noncontact ultrasound 
indentation system for measurement of tissue material properties using 
water jet compression. Ultrasound Med Biol. 2005;31:817-26. 
[182] Lu MH, Zheng YP, Huang QH, Ling C, Wang Q, Bridal L, et al. 
Noncontact evaluation of articular cartilage degeneration using a novel 
ultrasound water jet indentation system. Ann Biomed Eng. 2009;37:164-
75. 
[183] Lyyra T, Jurvelin J, Pitkänen P, Väätäinen U and Kiviranta I. 
Indentation instrument for the measurement of cartilage stiffness under 
arthroscopic control. Med Eng Phys. 1995;17:395-9. 
[184] Mak AF, Lai WM and Mow VC. Biphasic indentation of articular 
cartilage. I. Theoretical analysis. J Biomech. 1987;20:703-14. 
[185] Malemud CJ, Islam N and Haqqi TM. Pathophysiological 
mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells 
Tissues Organs. 2003;174:34-48. 
[186] Manicourt DH, Azria M, Mindeholm L, Thonar EJ and Devogelaer 
JP. Oral salmon calcitonin reduces Lequesne's algofunctional index scores 
and decreases urinary and serum levels of biomarkers of joint metabolism 
in knee osteoarthritis. Arthritis Rheum. 2006;54:3205-11. 
[187] Mankin HJ and Lippiello L. Biochemical and metabolic 
abnormalities in articular cartilage from osteo-arthritic human hips. J 
Bone Joint Surg Am. 1970;52:424-34. 
[188] Mankin HJ, Dorfman H, Lippiello L and Zarins A. Biochemical and 
metabolic abnormalities in articular cartilage from osteo-arthritic human 
hips. II. Correlation of morphology with biochemical and metabolic data. 
J Bone Joint Surg Am. 1971;53:523-37. 
[189] Mankin HJ. The response of articular cartilage to mechanical injury. 
J Bone Joint Surg Am. 1982;64:460-6. 
[190] March LM and Bachmeier CJ. Economics of osteoarthritis: a global 
perspective. Baillieres Clin Rheumatol. 1997;11:817-34. 
[191] Maroudas A, Bayliss MT, Uchitel-Kaushansky N, Schneiderman R 
and Gilav E. Aggrecan turnover in human articular cartilage: use of 
aspartic acid racemization as a marker of molecular age. Arch Biochem 
Biophys. 1998;350:61-71. 
[192] Maroudas AI. Balance between swelling pressure and collagen 
tension in normal and degenerate cartilage. Nature. 1976;260:808-9. 
[193] Marti B, Knobloch M, Tschopp A, Jucker A and Howald H. Is 
excessive running predictive of degenerative hip disease? Controlled study 
of former elite athletes. Bmj. 1989;299:91-3. 
 98 
[194] McAlindon TE, LaValley MP, Gulin JP and Felson DT. 
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic 
quality assessment and meta-analysis. JAMA. 2000;283:1469-75. 
[195] McConnell S, Kolopack P and Davis AM. The Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC): a review of its 
utility and measurement properties. Arthritis Rheum. 2001;45:453-61. 
[196] Mitchell NS and Cruess RL. Classification of degenerative arthritis. 
Can Med Assoc J. 1977;117:763-5. 
[197] Mix KS, Sporn MB, Brinckerhoff CE, Eyre D and Schurman DJ. 
Novel inhibitors of matrix metalloproteinase gene expression as potential 
therapies for arthritis. Clin Orthop Relat Res. 2004;S129-37. 
[198] Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, 
Kuykendall DH, et al. A controlled trial of arthroscopic surgery for 
osteoarthritis of the knee. N Engl J Med. 2002;347:81-8. 
[199] Mow VC, Kuei SC, Lai WM and Armstrong CG. Biphasic creep and 
stress relaxation of articular cartilage in compression: Theory and 
experiments. J Biomech Eng. 1980;102:73-84. 
[200] Mow VC, Ratcliffe A and Poole AR. Cartilage and diarthrodial 
joints as paradigms for hierarchical materials and structures. 
Biomaterials. 1992;13:67-97. 
[201] Muehleman C, Li J, Wernick M, Brankov J, Kuettner K and Zhong 
Z. Yes, you can see cartilage with X-rays; diffraction enhanced X-ray 
imaging for soft and hard tissues. J Musculoskelet Neuronal Interact. 
2004a;4:369-70. 
[202] Muehleman C, Majumdar S, Issever AS, Arfelli F, Menk RH, Rigon 
L, et al. X-ray detection of structural orientation in human articular 
cartilage. Osteoarthritis Cartilage. 2004b;12:97-105. 
[203] Murphy G and Lee MH. What are the roles of metalloproteinases in 
cartilage and bone damage? Ann Rheum Dis. 2005;64 Suppl 4:iv44-7. 
[204] Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch 
G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis 
Rheum. 2008;59:1207-13. 
[205] Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et 
al. Evidence for altered synthesis of type II collagen in patients with 
osteoarthritis. J Clin Invest. 1998;102:2115-25. 
[206] Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I and Mainil-
Varlet P. Cartilage tissue engineering for degenerative joint disease. Adv 
Drug Deliv Rev. 2006;58:300-22. 
 99 
[207] Niederauer GG, Niederauer GM, Cullen LC, Jr., Athanasiou KA, 
Thomas JB and Niederauer MQ. Correlation of cartilage stiffness to 
thickness and level of degeneration using a handheld indentation probe. 
Ann Biomed Eng. 2004;32:352-9. 
[208] Nieminen HJ, Töyräs J, Rieppo J, Nieminen MT, Hirvonen J, 
Korhonen R, et al. Real-time ultrasound analysis of articular cartilage 
degradation in vitro. Ultrasound Med Biol. 2002;28:519-525. 
[209] Nieminen HJ, Saarakkala S, Laasanen MS, Hirvonen J, Jurvelin JS 
and Töyräs J. Ultrasound attenuation in normal and spontaneously 
degenerated articular cartilage. Ultrasound Med Biol. 2004;30:493-500. 
[210] Nieminen HJ, Töyräs J, Laasanen MS and Jurvelin JS. Acoustic 
properties of articular cartilage under mechanical stress. Biorheology. 
2006;43:523-35. 
[211] Nieminen HJ, Julkunen P, Töyräs J and Jurvelin JS. Ultrasound 
speed in articular cartilage under mechanical compression. Ultrasound 
Med Biol. 2007;33:1755-66. 
[212] Nieminen MT, Töyräs J, Rieppo J, Hakumäki JM, Silvennoinen J, 
Helminen HJ, et al. Quantitative MR microscopy of enzymatically 
degraded articular cartilage. Magn Reson Med. 2000;43:676-81. 
[213] Nieminen MT, Töyräs J, Rieppo J, Silvennoinen MJ, Hakumäki JM, 
Hyttinen MM, et al. T2 relaxation reveals spatial collagen architecture in 
articular cartilage: a comparative quantitative MRI and polarized light 
microscopic study. Magn Reson Med. 2001;46:487-93. 
[214] Nissi MJ, Töyräs J, Laasanen MS, Rieppo J, Saarakkala S, 
Lappalainen R, et al. Proteoglycan and collagen sensitive MRI evaluation 
of normal and degenerated articular cartilage. J Orthop Res. 2004;22:557-
64. 
[215] Oakley SP, Portek I, Szomor Z, Turnbull A, Murrell GA, Kirkham 
BW, et al. Accuracy and reliability of arthroscopic estimates of cartilage 
lesion size in a plastic knee simulation model. Arthroscopy. 2003;19:282-9. 
[216] Okazaki K and Sandell LJ. Extracellular matrix gene regulation. 
Clin Orthop Relat Res. 2004;S123-8. 
[217] Palmoski MJ and Brandt KD. Running inhibits the reversal of 
atrophic changes in canine knee cartilage after removal of a leg cast. 
Arthritis Rheum. 1981;24:1329-37. 
[218] Pan Y, Li Z, Xie T and Chu CR. Hand-held arthroscopic optical 
coherence tomography for in vivo high-resolution imaging of articular 
cartilage. J Biomed Opt. 2003;8:648-54. 
 100 
[219] Parsons JR and Black J. The viscoelastic shear behavior of normal 
rabbit articular cartilage. J Biomech. 1977;10:21-9. 
[220] Peach CA, Carr AJ and Loughlin J. Recent advances in the genetic 
investigation of osteoarthritis. Trends Mol Med. 2005;11:186-91. 
[221] Peat G, Thomas E, Duncan R, Wood L, Hay E and Croft P. Clinical 
classification criteria for knee osteoarthritis: performance in the general 
population and primary care. Ann Rheum Dis. 2006;65:1363-7. 
[222] Pelletier JP and Martel-Pelletier J. New trends in the treatment of 
osteoarthritis. Semin Arthritis Rheum. 2005;34:13-4. 
[223] Pelletier JP and Martel-Pelletier J. DMOAD developments: present 
and future. Bull NYU Hosp Jt Dis. 2007;65:242-8. 
[224] Peterfy CG, van Dijke CF, Janzen DL, Gluer CC, Namba R, 
Majumdar S, et al. Quantification of articular cartilage in the knee with 
pulsed saturation transfer subtraction and fat-suppressed MR imaging: 
optimization and validation. Radiology. 1994;192:485-91. 
[225] Petersson IF. Occurrence of osteoarthritis of the peripheral joints in 
European populations. Ann Rheum Dis. 1996;55:659-61. 
[226] Piscaer TM, Waarsing JH, Kops N, Pavljasevic P, Verhaar JA, van 
Osch GJ, et al. In vivo imaging of cartilage degeneration using microCT-
arthrography. Osteoarthritis Cartilage. 2008;16:1011-7. 
[227] Potter K, Kidder LH, Levin IW, Lewis EN and Spencer RG. Imaging 
of collagen and proteoglycan in cartilage sections using Fourier transform 
infrared spectral imaging. Arthritis Rheum. 2001;44:846-55. 
[228] Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell 
PA, et al. Osteoarthritis cartilage histopathology: grading and staging. 
Osteoarthritis Cartilage. 2006;14:13-29. 
[229] Puolakka TJ, Pajamaki KJ, Halonen PJ, Pulkkinen PO, 
Paavolainen P and Nevalainen JK. The Finnish Arthroplasty Register: 
report of the hip register. Acta Orthop Scand. 2001;72:433-41. 
[230] Qvist P, Bay-Jensen AC, Christiansen C, Dam EB, Pastoureau P 
and Karsdal MA. The disease modifying osteoarthritis drug (DMOAD): Is 
it in the horizon? Pharmacol Res. 2008;58:1-7. 
[231] Radin EL. Mechanical aspects of osteoarthrosis. Bull Rheum Dis. 
1976;26:862-5. 
[232] Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Labonte F, 
Beaudoin G, de Guise JA, et al. Quantitative magnetic resonance imaging 
evaluation of knee osteoarthritis progression over two years and 
correlation with clinical symptoms and radiologic changes. Arthritis 
Rheum. 2004;50:476-87. 
 101 
[233] Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, 
et al. Long-term effects of glucosamine sulphate on osteoarthritis 
progression: a randomised, placebo-controlled clinical trial. Lancet. 
2001;357:251-6. 
[234] Reichenbach S, Yang M, Eckstein F, Niu J, Hunter DJ, McLennan 
CE, et al. Do cartilage volume or thickness distinguish knees with and 
without mild radiographic osteoarthritis? The Framingham Study. Ann 
Rheum Dis. 2009; 
[235] Rieppo J, Töyräs J, Nieminen MT, Kovanen V, Hyttinen MM, 
Korhonen RK, et al. Structure-function relationships in enzymatically 
modified articular cartilage. Cells Tissues Organs. 2003;175:121-32. 
[236] Rieppo J, Hallikainen J, Jurvelin JS, Kiviranta I, Helminen HJ and 
Hyttinen MM. Practical considerations in the use of polarized light 
microscopy in the analysis of the collagen network in articular cartilage. 
Microsc Res Tech. 2008;71:279-87. 
[237] Roddy E and Doherty M. Changing life-styles and osteoarthritis: 
what is the evidence? Best Pract Res Clin Rheumatol. 2006;20:81-97. 
[238] Ronca F, Palmieri L, Panicucci P and Ronca G. Anti-inflammatory 
activity of chondroitin sulfate. Osteoarthritis Cartilage. 1998;6 Suppl 
A:14-21. 
[239] Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K and 
Lohmander LS. Knee osteoarthritis after meniscectomy: prevalence of 
radiographic changes after twenty-one years, compared with matched 
controls. Arthritis Rheum. 1998;41:687-93. 
[240] Rubenstein JD, Kim JK, Morova-Protzner I, Stanchev PL and 
Henkelman RM. Effects of collagen orientation on MR imaging 
characteristics of bovine articular cartilage. Radiology. 1993;188:219-26. 
[241] Saarakkala S, Töyräs J, Hirvonen J, Laasanen MS, Lappalainen R 
and Jurvelin JS. Ultrasonic quantitation of superficial degradation of 
articular cartilage. Ultrasound Med Biol. 2004;30:783-92. 
[242] Saarakkala S, Laasanen MS, Jurvelin JS and Töyräs J. Quantitative 
ultrasound imaging detects degenerative changes in articular cartilage 
surface and subchondral bone. Phys Med Biol. 2006;51:5333-46. 
[243] Saied A, Cherin E, Gaucher H, Laugier P, Gillet P, Floquet J, et al. 
Assessment of articular cartilage and subchondral bone: subtle and 
progressive changes in experimental osteoarthritis using 50 MHz 
echography in vitro. Journal of bone and mineral research. 1997;1378-
1386. 
 102 
[244] Sangha O. Epidemiology of rheumatic diseases. Rheumatology 
(Oxford). 2000;39 Suppl 2:3-12. 
[245] Schaible HG, Schmelz M and Tegeder I. Pathophysiology and 
treatment of pain in joint disease. Adv Drug Deliv Rev. 2006;58:323-42. 
[246] Schouten JS, van den Ouweland FA and Valkenburg HA. A 12 year 
follow up study in the general population on prognostic factors of 
cartilage loss in osteoarthritis of the knee. Ann Rheum Dis. 1992;51:932-7. 
[247] Schurman DJ and Smith RL. Osteoarthritis: current treatment and 
future prospects for surgical, medical, and biologic intervention. Clin 
Orthop Relat Res. 2004;S183-9. 
[248] Schwartz DE, Choi Y, Sandell LJ and Hanson WR. Quantitative 
analysis of collagen, protein and DNA in fixed, paraffin-embedded and 
sectioned tissue. Histochem J. 1985;17:655-63. 
[249] Segal NA, Buckwalter JA and Amendola A. Other surgical 
techniques for osteoarthritis. Best Pract Res Clin Rheumatol. 2006;20:155-
76. 
[250] Sharma L, Lou C, Cahue S and Dunlop DD. The mechanism of the 
effect of obesity in knee osteoarthritis: the mediating role of malalignment. 
Arthritis Rheum. 2000;43:568-75. 
[251] Silvast TS, Jurvelin JS, Aula AS, Lammi MJ and Töyräs J. Contrast 
agent-enhanced computed tomography of articular cartilage: association 
with tissue composition and properties. Acta Radiol. 2009a;50:78-85. 
[252] Silvast TS, Jurvelin JS, Lammi MJ and Töyräs J. pQCT study on 
diffusion and equilibrium distribution of iodinated anionic contrast agent 
in human articular cartilage--associations to matrix composition and 
integrity. Osteoarthritis Cartilage. 2009b;17:26-32. 
[253] Spahn G, Plettenberg H, Kahl E, Klinger HM, Muckley T and 
Hofmann GO. Near-infrared (NIR) spectroscopy. A new method for 
arthroscopic evaluation of low grade degenerated cartilage lesions. Results 
of a pilot study. BMC Musculoskelet Disord. 2007;8:47. 
[254] Spector TD, Hart DJ and Doyle DV. Incidence and progression of 
osteoarthritis in women with unilateral knee disease in the general 
population: the effect of obesity. Ann Rheum Dis. 1994;53:565-8. 
[255] Spector TD, Cicuttini F, Baker J, Loughlin J and Hart D. Genetic 
influences on osteoarthritis in women: a twin study. Bmj. 1996;312:940-3. 
[256] Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline 
GA, Beary JF, et al. Effect of risedronate on joint structure and 
symptoms of knee osteoarthritis: results of the BRISK randomized, 
controlled trial [ISRCTN01928173]. Arthritis Res Ther. 2005;7:R625-33. 
 103 
[257] Steinmeyer J and Konttinen YT. Oral treatment options for 
degenerative joint disease--presence and future. Adv Drug Deliv Rev. 
2006;58:168-211. 
[258] Stockwell RA. The cell density of human articular and costal 
cartilage. J Anat. 1967;101:753-63. 
[259] Stolz M, Raiteri R, Daniels AU, VanLandingham MR, Baschong W 
and Aebi U. Dynamic elastic modulus of porcine articular cartilage 
determined at two different levels of tissue organization by indentation-
type atomic force microscopy. Biophys J. 2004;86:3269-83. 
[260] Suh JK, Youn I and Fu FH. An in situ calibration of an ultrasound 
transducer: a potential application for an ultrasonic indentation test of 
articular cartilage. J Biomech. 2001;34:1347-53. 
[261] Toivanen AT, Arokoski JP, Manninen PS, Heliovaara M, Haara MM, 
Tyrvainen E, et al. Agreement between clinical and radiological methods 
of diagnosing knee osteoarthritis. Scand J Rheumatol. 2007;36:58-63. 
[262] Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, 
Robinson V, et al. Glucosamine therapy for treating osteoarthritis. 
Cochrane Database Syst Rev. 2005;CD002946. 
[263] Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC and 
Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 
2006;CD004257. 
[264] Töyräs J, Rieppo J, Nieminen MT, Helminen HJ and Jurvelin JS. 
Characterization of enzymatically induced degradation of articular 
cartilage using high frequency ultrasound. Phys Med Biol. 1999;44:2723-
33. 
[265] Töyräs J, Lyyra-Laitinen T, Niinimäki M, Lindgren R, Nieminen 
MT, Kiviranta I, et al. Estimation of the Young's modulus of articular 
cartilage using an arthroscopic indentation instrument and ultrasonic 
measurement of tissue thickness. J Biomech. 2001;34:251-6. 
[266] Töyräs J, Laasanen MS, Saarakkala S, Lammi MJ, Rieppo J, 
Kurkijärvi J, et al. Speed of sound in normal and degenerated bovine 
articular cartilage. Ultrasound Med Biol. 2003;29:447-54. 
[267] Urquhart DM, Soufan C, Teichtahl AJ, Wluka AE, Hanna F and 
Cicuttini FM. Factors that may mediate the relationship between physical 
activity and the risk for developing knee osteoarthritis. Arthritis Res 
Ther. 2008;10:203. 
[268] van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP and 
Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. 
 104 
Comparison of radiological osteoarthritis in a Dutch population with that 
in 10 other populations. Ann Rheum Dis. 1989;48:271-80. 
[269] Verbrugge LM and Patrick DL. Seven chronic conditions: their 
impact on US adults' activity levels and use of medical services. Am J 
Public Health. 1995;85:173-82. 
[270] Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, et 
al. Effect of collagen turnover on the accumulation of advanced glycation 
end products. J Biol Chem. 2000;275:39027-31. 
[271] Winalski CS, Shortkroff S, Schneider E, Yoshioka H, Mulkern RV 
and Rosen GM. Targeted dendrimer-based contrast agents for articular 
cartilage assessment by MR imaging. Osteoarthritis Cartilage. 2008;16:815-
22. 
[272] Viren T, Saarakkala S, Kaleva E, Jurvelin JS and Töyräs J. Novel 
Mini-Invasive Ultrasound Method for Intra-Articular Diagnostics of 
Cartilage Degeneration. Trans Orthop Res Soc. 2009;55:1123. 
[273] Wluka AE, Wolfe R, Stuckey S and Cicuttini FM. How does tibial 
cartilage volume relate to symptoms in subjects with knee osteoarthritis? 
Ann Rheum Dis. 2004;63:264-8. 
[274] Wooley PH, Grimm MJ and Radin EL. The structure and function 
of joints. In editors. Arthritis and allied conditions : a textbook of 
rheumatology. Vol. 1, pages 149-173. Philadelphia: Lippincott Williams & 
Wilkins; 2005. 
[275] Treatment of knee and hip osteoarthritis (online). Current Care 
Summary [homepage on the Internet]. The Finnish Medical Society 
Duodecim; 2007 [cited Available from: http://www.kaypahoito.fi/ 
[276] Xia Y, Moody JB, Burton-Wurster N and Lust G. Quantitative in 
situ correlation between microscopic MRI and polarized light microscopy 
studies of articular cartilage. Osteoarthritis Cartilage. 2001;9:393-406. 
[277] Xie L, Lin AS, Levenston ME and Guldberg RE. Quantitative 
assessment of articular cartilage morphology via EPIC-microCT. 
Osteoarthritis Cartilage. 2009;17:313-20. 
[278] Xie T, Guo S, Zhang J, Chen Z and Peavy GM. Use of polarization-
sensitive optical coherence tomography to determine the directional 
polarization sensitivity of articular cartilage and meniscus. J Biomed Opt. 
2006;11:064001. 
[279] Xie T, Xia Y, Guo S, Hoover P, Chen Z and Peavy GM. 
Topographical variations in the polarization sensitivity of articular 
cartilage as determined by polarization-sensitive optical coherence 
 105 
tomography and polarized light microscopy. J Biomed Opt. 
2008;13:054034. 
[280] Yelin E and Callahan LF. The economic cost and social and 
psychological impact of musculoskeletal conditions. National Arthritis 
Data Work Groups. Arthritis Rheum. 1995;38:1351-62. 
[281] Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P and 
Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact 
on functional status among the elderly: The Framingham Study. Am J 
Epidemiol. 2002;156:1021-7. 
 
 

  
 
 
 
ORIGINAL PUBLICATIONS 
Kuopio University Publications D. Medical Sciences 
 
 
D 434. Hassinen, Maija. Predictors and consequences of the metabolic syndrome: population-based 
studies in aging men and women.  
2008. Acad. Diss. 
 
D 435. Saltevo, Juha. Low-grade inflammation and adiponectin in the metabolic syndrome.  
2008. 109 p. Acad. Diss. 
 
D 436. Ervasti, Mari. Evaluation of Iron Status Using Methods Based on the Features of Red Blood 
Cells and Reticulocytes.  
2008. 104 p. Acad. Diss. 
 
D 437. Muukka, Eija. Luomun tie päiväkotiin: luomuruokailun toteutettavuus ja ravitsemuksellinen 
merkitys päiväkotilapsille.  
2008. 168 p. Acad. Diss.  
 
D 438. Sörensen, Lars. Work ability and health-related quality of life in middle-aged men: the role 
of physical activity and fitness.  
2008. 83 p. Acad. Diss.  
 
D 439. Maaranen, Päivi. Dissociation in the finnish general population.  
2008. 97 p. Acad. Diss.  
 
D 440. Hyvönen, Juha. Suomen psykiatrinen hoitojärjestelmä 1990-luvulla historian jatkumon 
näkökulmasta. 2008. 279 p. Acad. Diss.  
 
D 441. Mäkinen, Heidi. Disease activity and remission in rheumatoid arthritis: comparison of 
available disease activity measures and development of a novel disease sctivity indes: the mean overall 
index for rheumatoid arthritis (MOI-RA).  
2008. 129 p. Acad. Diss.  
 
D 442. Kousa, Anne. The regional association of the hardness in well waters and the incidence of 
acute myocardial infarction in rural Finland.  
2008. 92 p. Acad. Diss.  
 
D 443. Olkku, Anu. Glucocorticoid-induced changes in osteoblastic cells: cross-talk with wnt and 
glutamate signalling pathways. 
2009. 118 p. Acad. Diss. 
 
D 444. Mattila, Riikka. Effectiveness of a multidisciplinary lifestyle intervention on hypertension, 
cardiovascular risk factors and musculoskeletal symptoms. 
2009. 92 p. Acad. Diss. 
 
D 445. Hartmann-Petersen, Susanna. Hyaluronan and CD44 in epidermis with special reference 
to growth factors and malignant transformation. 
2009. 103 p. Acad. Diss. 
 
D 446. Tolppanen, Anna-Maija. Genetic association of the tenomodulin gene (TNMD) with 
obesity- and inflammation-related phenotypes. 
2009. 111 p. Acad. Diss. 
 
D 447. Lehto, Soili Marianne. Biological findings in major depressive disorder with special 
reference to the atypical features subtype.  
2009. 115 p. Acad. Diss.  
 
D 448. Nieminen, Jyrki. Effect of functional loading on remodelling in canine, and normal and 
collagen type II transgenic murine bone.  
2009. 107 p. Acad. Diss.  
 
D 449. Torpström, Jaana. Yliopistokoulutus ravitsemusasiantuntijuuden kehittäjänä.  
2009. 164 p. Acad. Diss.  
